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Cobalamin or vitamin B12 is one of the most complex small molecules produced 
by prokaryotic organisms. B12 is a member of the metabolically diverse group of 
compounds called tetrapyrroles, whose members include haem, chlorophyll, 
sirohaem and co-enzyme F430. The metabolic activity of B12 is dependent upon the 
cobalt ion located at the centre of a contracted corrin macrocycle. Replacement 
of this central cobalt ion with an alternative metal ion results in the formation of 
a compound that structurally resembles B12 but shares none of its vitamin 
function. Zincobalamin (Zbl), the zinc analogue of B12, was synthesised from an 
intermediate of B12 biosynthesis, hydrogenobyrinic acid a, c diamide (HBAd). This 
intermediate is the last metal-free intermediate of B12 biosynthesis. The synthesis 
of Zbl from HBAd involves a combination of chemical synthesis and biochemical 
modification of the starting material. Regiospecific amidation of 4 out the 5 
carboxylic acid sidechains decorating the macrocycle of HBAd is required in order 
to produce Zbl. During B12 biosynthesis these amidations are catalysed by a single 
enzyme CobQ. Previously characterised CobQs are highly specific for a cobalt 
containing intermediate of B12 biosynthesis. A CobQ capable of acting ͞out of 
tuƌŶ͟ ǁith ƌespeĐt to the Ŷoƌŵal order of B12 biosynthesis was identified within 
the genome of Allochromatium vinosum. This enzyme was used to good effect in 
the conversion of HBAd into hexa-amidated compound called hydrogenobyric 
acid (Hby), the metal free analogue of a late intermediate of B12 biosynthesis 
cobyric acid. A structural reason as to why A. vinousm CobQ is able to recognise 
HBAd as a substrate was investigated through sequence alignment and structural 
prediction. The remaining steps towards Zbl synthesis were completed chemically 
through the abiotic insertion of zinc into the macrocycle of Hby and the 
attachment of the pre-fabricated lower nucleotide loop. As both Hby and its zinc 
containing counterpart have not been previously described in the literature all 
three compounds including Zbl were subject to biochemical characterisation by 
UV-visible, NMR and mass spectroscopy. The influence of these analogues on the 
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1:1:1 Introduction to B12 
Modified tetrapyrroles are a group of molecules found across all kingdoms of life. 
Members of this family include the light harvesting pigment chlorophyll, the 
oxygen binding and redox active haems, the methanogenic pigment coenzyme 
F430 and the cobalamins (Battersby 2000, Scott 1993, Blanche et al 1995). As the 
most chemically complex member of the modified tetrapyrroles, cobalamins are 
comprised of a 19 membered corrin ring contrasting the 20 membered rings of 
haem, chlorophyll and coenzyme F430 (Figure 1:1:1). Structurally, cobalamins 
extend into three dimensions by way of a lower nucleotide loop attached directly 
to the propionate sidechain f and an upper ligand attached directly to a central 
cobalt ion. The term cobalamin describes a number of different compounds, the 
uniting factor for this class of molecule is an identical 19 membered corrin ring 
with a centrally chelated cobalt ion. Variations within the cobalamins exist 
regarding the identity of the lower nucleotide loop as well as the upper axial 
ligand (Helliwell et al 2016, Krautler et al 1987, Stupperich et al 1988). 
Cobalamins found in nature can harbour a number of different ligands attached 
to the uppeƌ β face of the central cobalt ion. The best studied of these B12 variants 
are adenosyl and methyl cobalamin (Ado-Cbl and Me-Cbl), where the uppeƌ β 
ligand is either an adenosine or a methyl group. Significantly these groups are 
attached directly to the central cobalt ion by way of an organometallic carbon 
cobalt bond (Kräutler 2005). Without biological intervention the upper ligand of 
cobalamins can also be comprised of a number of different groups from 
halogenated derivatives to a hydroxyl group as in hydroxocobalamin (OH-Cbl) or 
cyanide as is the case for vitamin B12. The latter is a by-product of the industrial 
process used to extract B12. Technically vitamin B12 refers only to cyano-cobalamin 
but the term B12 is often used more loosely to refer to cobalamins in general. 
A shared trait of the naturally occurring tetrapyrroles is the presence of a metal 
ion at the centre of the macrocycle. Chlorophylls contain magnesium within a 
chlorin ring, haems have an iron at the centre of a porphyrin ring and F430 has a 
nickel ion entrapped within an isobacteriochlorin ring. Cobalamin is no exception 
to this containing a cobalt ion at the centre of a corrin ring. It is thought that by 
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entrapping metals in a tetrapyrrolic ring the reactivity of the metal ion can be 
modulated and made more compatible with the predominantly protein based 
chemistry essential to life (Eschenmoser 1988). In the case of chlorophylls the 
central magnesium ion plays more of a structural role maintaining a planar 
conformation of the chlorin ring (Fiedor et al 2008). In cyanobacteria the central 
magnesium ion plays an additional role in the supramolecular organisation of 
chlorophylls in chlorosomes (Tamiaki 1996, Olsen 1998).  
The different ring types found within the tetrapyrrole family probably represent 
Ŷatuƌe͛s tuning of the reactivity of each metal centre, this is probably the 
evolutionary driving force behind the production of these compounds. The 
organic scaffolds provided by B12, haem, chlorophyll and F430 allow access to the 
chemistry of these metal ions that may have otherwise been unavailable to 















Figure 1:1:1: Naturally occurring tetrapyrroles. Clockwise from top, Chlorophyll a 
magnesium containing modified chlorin. Coenzyme F430 a nickel containing modified 
isobacteriochlorin. Cobalamin a highly modifed corrin and Haem B a modified iron 
containing porhyrin.  
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1:1:2 Biological role of B12 
B12 and other cobalt containing corrins are essential cofactors in numerous 
biological processes required by both eukaryotic and prokaryotic organisms. The 
biological activity of the various cobalamins implicated in biological process is 
dependent upon the cobalt ion found at the centre of these compounds 
(Eschenmoser 2011). In particular it is the ability of the central cobalt ion to form 
stable organo-metallic bonds as well as the high nucleophilicity of the Co1+ species 
it is possible to form (Banerjee 2003, Marsh et al 2001).   
The forms of cobalamin most relevant for human health, and consequently the 
best studied, are Me-Cbl and Ado-Cbl (Banerjee et al 2003). These co-factors 
harbour a unique organo-metallic bond between the central cobalt ion and the 
oƌgaŶiĐ uppeƌ β ligaŶd. The Đellulaƌ fuŶĐtioŶs of both Me-Cbl and Ado-Cbl rely 
upon the properties of these carbon cobalt bonds (Banerjee et al 2003, Matthews 
et al 2011).  
The properties of the C-Co bond in Ado-Cbl is such that homolytic cleavage of this 
bond can occur with relative ease resulting in the formation of an adenosyl radical 
(Marsh et al 2010). This radical is utilised for a variety of carbon skeleton 
rearrangements, the C-C bond reorganisations catalysed by Ado-Cbl requiring 
enzymes play a vital role in the metabolism of a range of organisms (Reitzer et al 
1999, Masuda et al 2000, Mancia et al 1996). From a human health perspective 
this radical chemistry is required for the interconversion of methylmalonyl-CoA 
and succinyl-CoA as part of the catabolism of odd chain fatty acids and branched 
amino acids. The conversion of methylmalonyl-CoA to its isomer succinyl-CoA is 
catalysed by methylmalonyl-CoA mutase (Mancia et al 1998). A deficiency in this 
enzyme results in the build-up of methylmalonylic acid leading to the condition 
methylmalonate acidemia and in extreme cases can lead to neurological damage 
(Allen et al 1993). The same enzyme is a feature of bacterial metabolism where 
methylmalonyl CoA mutase plays an important role in the production of 
propionate in Propionibacterium, here the reverse reaction is favoured and 
succinate is converted to methylmalonylic acid en route to propionic acid (Allen 
et al 1964). 
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The carbon-cobalt bond found in Ado-Cbl is unstable under conditions of 
illumination. Light induced cleavage of this bond occurs homolytically resulting in 
the formation of an adenosyl radical and a pentacoordinate Co2+ species in both 
oxygenic and anoxic environments (Schwartz et al 2007, Walker et al 1998). 
Unless the adenosyl radical is otherwise directed it is possible to reform Ado-Cbl 
through reaction with the central cobalt of the parent molecule. However, the 
main pathway by which the adenosyl radical is lost when Ado-Cbl is illuminated is 
through reaction with molecular oxygen foƌŵiŶg adeŶosǇl ϱ͛ aldehǇde (Finke and 
Hay 1984). Undeƌ aŶoǆiĐ ĐoŶditioŶs ϱ͛ ϴ͛ ĐǇĐloadeŶosiŶe is foƌŵed instead (Law 
et al 1973, Hogenkamp 1963). The sensitivity of Ado-Cbl to a broad spectrum of 
light underpins its function as a light sensing pigment in some photosynthetic 
bacteria (Cheng et al 2014, Guerrero et al 2011).  
One such light sensor CarH has been described in detail. CarH controls the 
expression of genes associated with carotenoid biosynthesis under conditions of 
illumination (Guerrero et al 2011). Carotenoids are produced by a number of 
photosynthetic organisms to protect against light induced oxidative damage 
(Armstrong et al 1997). The biosynthesis of these often complex small molecules 
is therefore limited to conditions where photo-oxidative damage is likely.  CarH 
acts as a light inducible transcription factor supressing the transcription of the 
carotenoid biosynthetic operon in Myxococcus xanthus in the absence of light 
(Perez-Marin et al 2007). The mechanism of this suppression is based upon the 
oligomeric state of the protein and consequently the DNA binding capability of 
CarH. In the absence of light with an intact Ado-Cbl bound this protein exists as a 
homo-tetramer with Ado-Cbl bound to each monomer, the stability of the 
tetramer being dependent upon the presence of Ado-Cbl. Photolysis of the carbon 
cobalt bond of Ado-Cbl results in the formation of an adenosyl radical, which due 
to pƌoǆiŵitǇ to the geŶoŵiĐ DNA of the oƌgaŶisŵ is diƌeĐted to foƌŵ ϰ͛, ϱ͛ –
anhydroxyadeonsine before it can induce DNA damage (Jost et al 2015). Loss of 
the adenosyl group from Ado-Cbl causes dissociation of the CarH tetramer 
allowing transcription of the carotenoid biosynthetic operon. 
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Ado-Cbl plays a role in the synthesis of deoxyribonucleotides from the 
corresponding ribonucleotide and is the co-factor required for a family of 
enzymes termed ribonucleotide reductases (Tauer and Brenner 1997). Three 
distinct families of ribonucleotide reductase exist all involved in the synthesis of 
deoxyribonucleotides from ribonucleotides (Norlund and Reichard 2006). All 
ribonucleotide reductases rely on a radical mechanism to produce 
deoxyribonucleotides from the corresponding ribonucleotide, they differ only in 
how this adenosyl radical is generated. Class II ribonucleotide reductases are Ado-
Cbl dependent and found solely in prokaryotes they rely on the generation of an 
adeŶosǇl ƌadiĐal to ƌeduĐe the Ϯ͛ ĐaƌďoŶ of a ƌiďoŶuĐleotide iŶ oƌdeƌ to pƌoduĐe 
the corresponding deoxyribonucleotide (Norlund and Reichard 2006). 
Interestingly class III ribonucleotide reductases uses an adenosyl radical 
generated from S-adenosyl methionine to perform the same reaction (Fontecave 
et al 2002). The fact that SAM can be coaxed into forming an adenosyl radical 
under certain conditions as well as sharing many of the same cellular functions as 
Ado-Cbl and Me-Cbl in terms of adenosyl radical formation and methyl 
transferase activity has led to SAM being described as a ͞pooƌ ŵaŶ͛s ĐoďalaŵiŶ͟ 
(Frey 2001). The apparent redundancy of these two cofactors is reconciled 
somewhat in B12 dependent radical SAM methylases and isomerases. Theses dual 
cofactor enzymes bind both SAM and methyl or hydroxyl cobalamin and catalyse 
a number of challenging methylations of un-activated carbon and phosphorous 
centres (Bauerle et al 2015, Broderick et al 2014). This class of enzyme is leveraged 
by a large number of bacteria for the production of secondary metabolites, 
particularly a number of compounds with anti-microbial properties (Bridwell et al 
2017, Zhou et al 2016). The enzyme BchE involved in the anaerobic biosynthesis 
of bacteriochlorophylls has been shown to be a dual cofactor SAM, Ado-B12 
dependent radical isomerase. Studies conducted with R. capsulatus 
demonstrated that BchE requires B12 in order to catalyse the cyclisation of ring E 
(Gough et al 2000). In higher plants ring E cyclisation is achieved by the action of 
a haem dependent monooxygenase (Heys and Hunter 2009). 
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The second organometallic cobalamin derivative, Me-Cbl, is required for 
methionine biosynthesis in both humans and bacteria (Banerjee et al 1990, 
Drennan et al 1994). In humans, methionine synthase activity is linked intimately 
with folate metabolism, specifically the recycling of methyl-tetrahydrofolate 
though transfer of the methyl group from methyl tetrahydrofolate to cobalamin 
forming Me-Cbl and tetrahydrofolate. This same methyl group is then transferred 
from Me-Cbl to homocysteine forming methionine and freeing the Cbl cofactor 
for another round of catalysis.  In bacteria this methionine synthase is encoded 
by the metH gene and allows for the synthesis of methionine under anaerobic 
conditions (Banerjee et al 1990). Mechanistically the methyl group of methyl 
tetrahydrofolate is transferred to a Co1+ B12 species to form methyl-cobalamin 
before this same methyl group is transferred to homocysteine to form 
methionine. This folate recycling system is leveraged by acetogenic bacteria for 
the fixation of CO2 via the Wood Ljungdahl pathway (Ragsdale 2008). In both 
these cases it is due to the unique properties of Me-Cbl,  particularly the ability of 
the ĐeŶtƌal Đoďalt ioŶ to ďe ƌeduĐed to a ͞supeƌŶuĐleophiliĐ͟ Co1+ species that 
allows for the efficient transfer of the methyl group from methyl-tetrahydrofolate 
(Liptak et al 2006).        
The cobalt ion at the centre of B12 has been implicated as the catalytic centre in a 
number of dehalogenase enzymes. These reductive dehalogenases are found in a 
variety of bacteria, where halogenated organic molecules can be used as part of 
anaerobic respiration. The dehalogenation activity of B12 has important 
implications for the environmental breakdown of halogenated pesticides and 
bioremediation of contaminated soils and waterways (Collins et al 2015).  






1:1:3 Discovery of cobalamin and elucidation of its biosynthetic pathway 
B12 was first discovered through efforts to treat patients suffering from a 
condition known as pernicious anaemia. The cause of this disease, while unknown 
at the time, was later found to be due to a deficiency in B12 uptake and therefore 
levels of B12 that are too low for normal metabolic function. Modern management 
of pernicious anaemia involves periodic subcutaneous injections of a B12 solution, 
prior to discovery of this treatment pernicious anaemia was a fatal condition. 
Early work towards an effective treatment for pernicious anaemia and the 
subsequent isolation of B12 began when physician George Whipple first noticed 
the curative effects of raw liver in patients suffering from this condition. Through 
fractionation of large quantities of raw liver more concentrated isolates with 
greater curative properties could be generated. Continuing on from this work 
George Minot and William Murphy would eventually isolate a bright red 
compound from these liver fractions that was sufficient to reverse the symptoms 
of pernicious anaemia. For this work all three would receive the 1934 Nobel Prize 
in physiology and medicine (Minot and Murphy 1926).  
While treatment of pernicious anaemia with these liver isolates was a vast 
improvement over the initial treatment of the consumption of 100 g of liver a day, 
the curative factor contained within these fractions (B12) would not be isolated 
until 1948. Initially a bioassay method was implemented for screening various 
fractions from beef liver for B12 (Shorb 1947). This method was based on the 
requirement of Lactobacillis lactis for B12 under certain growth conditions and was 
developed by Mary Shaw Shorb. This relatively high throughput method would 
greatly aid in the eventual isolation of B12. The isolation of B12, however, was 
achieved in parallel in an industrial setting when chromatographic separation 
techniques were used to isolate B12 from fractions of liver. The groups of Karl 
Folkers at Merck and Lester Smith at Glaxo were able to isolate small quantities 
of the red water soluble B12 for the first time (Rickes et al 1948, Smith 1948). 
The isolation of B12 led to studies designed to deduce the structure of this vitamin. 
Early structural studies using traditional degradative methods were undertaken 
by Karl Folkers at Merck and Alexander Todd at Cambridge. This approach led to 
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the conclusion that B12 was possibly a tetrapyrrole containing cobalt with a 
nucleotide attached in some fashion (Bonnett 1963). These degradative 
experiments led to the conclusion that cobalamin was structurally more complex 
than either haem or chlorophyll and as such a different methodology would be 
required to determine the structure. The structures of both haem and chlorophyll 
were well known at this time having been determined by degradative means by 
‘iĐhaƌd Willstatteƌ aŶd HaŶs FisĐheƌ iŶ the ϭϵϮϬ͛s aŶd ϭϵϯϬ͛s ƌespeĐtiǀelǇ ;FisĐheƌ 
1930). 
X-ray crystallography would prove to be the technique by which the structure of 
B12 was revealed. However, B12 was not the first corrin to have its structure solved 
by X-ray crystallography. While investigating the alkaline hydrolysis of the 
peripheral amides of B12 a ŵeŵďeƌ of AleǆaŶdeƌ Todd͛s gƌoup inadvertently 
produced crystals of cobyrinic acid c lactam (Figure 1:1:2). The quality of these 
crystals was sufficient to be analysed by X-ray crystallography (Hodgkin et al 
1955).    
Dorothy Crowfoot Hodgkin, one of the early pioneers of X-ray crystallography as 
a structural technique, eventually solved the structure of cobyric acid c lactam. 
She revealed for the first time the asymmetric corrin ring complete with central 
cobalt ion. Microbiological work revealed that the cyanide ligand present in the 
original crystals was an artefact of the extraction from liver using charcoal and 
that the biologically active form of cobalamin had an adenosyl group somehow 
associated with the molecule. The later crystal structure of adenosyl-cobalamin 
revealed that the adenosyl group is attached directly to the cobalt via a cobalt 
carbon bond. This was the first time that an organometallic bond had been 










Figure 1:1:2: The structure of the first deriviative of B12 solved as depicted on the left. Right 
the full structure of adenosylcobalamin. The pyrrole rings of adenosyl cobalamin are 
labelled A to D clockwise and the peripheral sidechains are labelled a-g. 
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1:1:4 Early steps of tetrapyrrole biosynthesis 
The biosynthesis of all tetrapyrroles begins from ɷ-aminolevulinic acid (ALA). Two 
distinct pathways for the biosynthesis of ALA are present in nature. The first of 
these pathways produces ALA via the condensation of glycine and succinyl-CoA. 
This pathway is known as the Shemin pathway and is present in humans and other 
higher eukaryotes; excluding plants and some bacteria, specifically α-
proteobacteria (Shemin and Rittenberg 1945). The second route, whereby ALA is 
synthesised from glutamate via a glutamyl-tRNA intermediate, is found in plants 
and most prokaryotes and is referred to as the C5 pathway (Beale 1970, Granick 
1950). Interestingly, the synthesis of ALA from glutamate is one of the few cellular 
process requiring a glutamyl-tRNA that is not related to translation.    
The condensation of two molecules of ALA gives the first pyrrole intermediate of 
tetrapyrrole biosynthesis, porphobilinogen (PBG). Through the asymmetric 
condensation of two molecules of ALA PBG is synthesised by the enzyme ALA 
dehydratase. Physiologically, ALA dehydratase exists in an equilibrium between 
an active octomeric form and a less active hexameric form (Van Hyningen and 
Shemin 1971).  
The first tetrapyrrolic intermediate is formed when 4 molecules of PBG are linked 
head to tail generating a linear tetrapyrrole, which is called hydroxymethylbilane 
(HMB). The synthesis of HMB proceeds via deamination of PBG and is catalysed 
by the enzyme PBG deaminase. Early work concerning the mechanism of PBG 
deaminase revealed that this enzyme produces its own dipyrromethane cofactor 
through the deamination and subsequent linkage of two molecules of PBG. This 
cofactor is bound covalently to a cysteine residue within the active site of PBG 
deaminase. Four molecules of PBG are linked sequentially to the dipyrromethane 
cofactor with the subsequent loss of ammonia for each PBG unit that is attached. 
The linear bilane is released from the active site of PBG deaminase, after 
hydrolysis of the linkage between dipyrromethane and the tetrapyrrole. 
Hydroxymethylbilane can cyclise spontaneously to form uroporphyrinogen I, 
without biological intervention (Figure 1:1:4). However, all tetrapyrroles derived 
from natural sources are ultimately derived from a different isomer of 
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uroporphyrinogen, uroporphyrinogen III ;uƌo͛geŶ IIIͿ. The different isomers of 
uroporphyrinogen are defined by the pattern of acetate and propionate 
sidechains attached to each pyrrole unit. Each of the pyrrole units that form all 
tetrapyrroles are labelled A to D, with A being the first PBG unit added to PBG 
deaminase and D being the final PBG unit added before release of HMB. In order 
to foƌŵ uƌo͛geŶ III fƌoŵ HMB ring D must be inverted  with respect to the other 
pyrrole units of hydroxymethylbilane to give the proper patterning of acetate and 
propionate sidechains in the final product (Figure 1:1:4). 
The ĐǇĐlisatioŶ of HMB to giǀe uƌo͛geŶ III is aŶ eŶzǇŵe dƌiǀeŶ pƌoĐess ĐatalǇsed 
ďǇ uƌo͛geŶ III synthase. This monomeric protein catalyses the cyclisation of HMB 
aŶd iŶǀeƌsioŶ of ƌiŶg D ƌesultiŶg iŶ the foƌŵatioŶ of uƌo͛geŶ III the fiŶal ĐoŵŵoŶ 
precursor to all tetrapyrroles as the branch of tetrapyrrole biosynthesis resulting 
in the formation of haem and chlorophyll begins with decarboxylation of the 














Figure 1:1:3: the early steps in the biosynthesis of all tetrapyrroles. ALA can be synthesied 
by two routes either from glycine and succinyl CoA or via glutamic acid. 4 units are 
porphobilogen (PBG) are linked together to form the linear tetrapyrrole hydroxymethyl 
bilane. Of the 16 possible isomers of HMB that can be formed the final product of PBG 
deaminase has ring D inverted relative to the positons of the other three pyrrole units. HMB 
is cyclised by uroporphyrinogen III synthase. Uroporphyrinogen III is the precursor to all 









Figure 1:1:4: Cyclisation of hydroxymethylbilane. Route A is the uncatalysed 
ĐyĐlisation of HMB to uro’gen I while route B shows the ĐyĐlisation of HMB 
as Đatalysed ďy uro’gen III synthase. The resulting type III isomer shows the 
same pattern of acetate and propionate sidechains as all modified 
tetrapyrroles found in nature.  
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1:1:5 Determination of the intermediates of B12 biosynthesis  
Uroporphyrinogen III is the first macrocyclic intermediate for the biosynthesis of 
all modified tetrapyrroles and also represents the first branch point in the 
pathway as deĐaƌďoǆǇlatioŶ of the aĐetate sideĐhaiŶs deĐoƌatiŶg uƌo͛geŶ III sets 
this compound down the path for haem and chlorophyll biosynthesis (Heinmann 
et al 2008, Tanaka and Tanaka 2007). For B12 biosynthesis the first modification 
to uƌo͛geŶ III is the attachment of two S-adenosyl methionine derived methyl 
groups to carbons C2 and C7 of the macrocycle, a modification that generates 
precorrin-2. This intermediate also represents a branch as it is an intermediate for 
sirohaem biosynthesis and may be referred to in the context of sirohaem 
biosynthesis as dihydro-sirohydrochlorin (Raux et al 1997). Intermediates of B12 
biosynthesis are designated ͞pƌeĐoƌƌiŶs͟ ǁith the pƌoĐeediŶg Ŷuŵďeƌ iŶdiĐatiŶg 
how many methyl groups have been added to the macrocycle of the molecule 
(Battersby 2000, Blanche et al 1995).  
AdditioŶ of the fiƌst tǁo ŵethǇl gƌoups to uƌo͛geŶ III is ĐatalǇsed ďǇ the uƌo͛geŶ 
III methyl transferase, an enzyme that has a remarkably slow turnover rate of 
approximately 38 h-1.  This enzyme, CobA, is subject to inhibition by one of its 
products, S-adenosyl homocysteine as well as by the tetrapyrrolic substrate 
uƌo͛geŶ III at ĐoŶĐeŶtƌations above 2 ʅM ;BlaŶĐhe et al ϭϵϴϵͿ. It is thought that 
the combination of slow turnover rate and both product and substrate inhibition 
seƌǀes to liŵit fluǆ of uƌo͛geŶ III toǁaƌds B12 biosynthesis as this compound is 
required in significantly lower levels than both haem, chlorophyll. The synthesis 
of coenzyme F430 also occurs via the oxidised form of precorrin-2, sirohydrochlorin 
(Moore et al 2017). As coenzyme F430 is required in large amounts for 
methanogenic prokaryotes the same product inhibition is not present in the CobA 
like protein required for addition of methyl groups to CϮ aŶd Cϲ of uƌo͛geŶ III 
(Blanche et al 19913). 
The pathways for haem and chlorophyll biosynthesis diverge at uƌo͛geŶ III ǀia 
decarboxylation of the 4 acetic acid sidechains to form coproporphyrinogen III. 
Some organisms are able to make haem via a different route starting with 
sirohaem, which begins its biosynthesis with the oxidised form of precorrin-2 
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sirohydrochlorin (Bali et al 2014). However, to direct precorrin-2 towards B12 
biosynthesis a third methyl group is added to the C20 positon of precorrin-2. CobI 
catalyses the addition of this third SAM derived methyl group to the C20 positon 
of precorrin-2 to form precorrin-3a. This methyl carbon will later be extruded and 
lost as acetate during the ring contraction process that yields the 19 membered 
corrin ring of B12 (Crouzet et al 1990). 
The trimethylated intermediate precorrin-3a is a substrate for the next enzyme of 
the B12 biosynthetic pathway, CobG. This enzyme is a monooxygenase that 
attaches an oxygen atom derived from molecular oxygen to C20 of precorrin-3a 
to form a tertiary alcohol, this modification aids in the later extrusion of C20 (Scott 
et al 1993). In addition to hydroxylation of C20 CobG also mediates the formation 
of a ɶ lactone between the carboxylate group of sidechain a and C1 of precorrin-
3b. The result of these modifications is a compound that is primed for contraction 
of the macrocycle by extrusion of C20 as an acyl group and direct bonding of C1 
and C19 of the corrin ring (Spencer et al 1993). 
While formation of the tertiary alcohol at C20 of precorrin-3 primes this molecule 
for ring contraction the actual ring contraction step is mediated by the next 
enzyme in the pathway CobJ. Extrusion of C20 to form an acyl group attached to 
C1 occurs concurrently with methylation of precorrin-3b at C17 to form the first 
19 membered intermediate of B12 biosynthesis, precorrin-4. Thus, both the 
methylation and ring contraction steps are catalysed by CobJ (Scott et al 1993).  
Precorrin-4 is methylated at the C11 positon by CobM (Schubert et al 1998). The 
structure of B12 shows that in the final product no methyl group is present at C11 
and instead two methyl groups are present at C12. Isotopic labelling studies have 
shown that the methyl group attached to C11 by CobM ultimately ends up at C12. 
The second α facing methyl group at C12 is derived for the later decarboxylation 
of the acetate sidechain at this positon. It has been postulated that methylation 
at the C12 positon would block this decarboxylation providing the chemical logic 
for the addition of a methyl group at C11 and its subsequent migration to C12 
(Thibaut et al 1992). 
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CobF catalyses the deacetylation of C1 and its subsequent replacement with a 
SAM derived methyl group (Min et al 1993). The chemical environment of this acyl 
group makes it highly labile. These carbon atoms are lost as acetic acid with the 
second oxygen atom required for acetic acid formation being derived from the 
solvent (Scott et al 1993). Following these modifications the macrocyclic oxidation 
level of precorrin-6a is higher than that of the final product (Blanche et al 1995). 
The next step of the biosynthesis addresses this disparity and a double bond of 
the dihydrocorrin macrocycle is reduced. Reduction of the double bond between 
C18 and C19 is performed by CobK and is NADPH dependent (Blanche et al 19922). 
Reduction of the dihydrocorrin by one NADPH derived hydrogen and one solvent 
derived hydrogen atom brings the oxidation state of the macrocyclic ring back to 
that of a corrin (Battersby 1993). The resulting compound precorrin-6b is the 
substrate for the next enzyme in the pathway CobL which adds the final two 
methyl groups to C5 and C15 of precorrin-6b (Blanche et al 19921). This enzyme, 
CobL also facilitates the decarboxylation of the acetate sidechain attached to C12. 
The methyl transferase activity for C5 and C15 can be separated and assigned to 
the N and C portions of CobL. Additionally the order of methylation has been 
shown to occur at C15 before methylation at C5. The decarboxylation and methyl 
transferase activities of the C terminus of CobL have not been separated. 
However, it has been proposed, that mechanistically, methylation is likely to 
precede decarboxylation as the two occur in a concerted process (Deerey et al 
2013). The methylation of C5 is catalysed by the N-terminus of CobL, overall, these 
steps result in the synthesis of precorrin-8. 
The subsequent step in the pathway involves an enzyme designated CobH which 
catalyses the suprafacial rearrangement of the methyl group from C11 to C12, in 
doing so precorrin-8 is converted to HBA. As a result of this methyl migration the 
ĐoŶjugated π sǇsteŵ eǆteŶds fƌoŵ Cϰ to Cϭϲ of the ĐoƌƌiŶ ŵaĐƌoĐǇĐle of HBA as 
it is no longer blocked by the presence of a tertiary carbon atom at C11 (Deery et 
al 2013, Thibaut et al 1992). Extension of this network of delocalised electrons 
results in a drastic change to the UV visible spectrum of HBA relative to precorrin-
8 reflective of the newly formed chromophore (Figure 1:1:4). 
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The synthesis of HBA from ALA represents the core of the cobalamin biosynthetic 
pathway. HBA has a corrin ring at the same oxidation level as the final product 
and the stereo chemistry of the peripheral sidechains is locked in by the presence 
of 8 methyl groups. The next steps in B12 biosynthesis concern the attachment of 
peripheral amide groups, insertion of cobalt and attachment of the upper and 














Figure 1:1:5: Section of the aerobic B12 biosynthetic pathway from 
uroporphyrinogen III to hydrogenobyrinic acid.  
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The peripheral sidechains of B12 are comprised of 3 propionamide and 3 
acetamide groups. The conversion of the carboxylic acid sidechains of HBA to their 
amide counterparts ďegiŶs ǁith the aŵidatioŶ of the tǁo β faĐiŶg aĐetate 
sidechains a and c. These groups are amidated by the glutamine dependent 
amidotransferase CobB. The amidation of these groups proceeds in an ordered 
fashion with sidechain c amidation occurring before amidation of sidechain a 
(Debussche et al 1990). The resulting compound hydrogenobyrinic acid a,c 
diamide (HBAd), is the substrate for cobalt insertion. 
The process of cobalt insertion is catalysed by the multi-component CobN, CobS 
and CobT chelation complex (Debussche et al 1992). CobNST shows sequence and 
structural homology to the magnesium chelatase complex involved in the 
synthesis of bacteriochlorophyll (Brindley et al 2003). The largest component of 
the cobaltochelatase complex is CobN. This 115 kDa protein is responsible for the 
binding of both cobalt and HBAd. CobS and CobT form a AAA ring-like complex 
and hydrolyses ATP in order to drive the process of Co2+ insertion into the corrin 
macrocycle of HBAd (Debussche et al 1992).  
Initially many of the cobalt containing intermediates from the aerobic pathway 
were generally isolated as their cyano derivatives. In vivo the cobalt containing 
intermediates of B12 biosynthesis harbour an adenosyl group on the uppeƌ β faĐe 
of the cobalt ion. Adenosylation, therefore, occurs relatively soon after insertion 
of cobalt, by a process that is catalysed by CobO (Debussche et al 1991). A number 
of adenosyl transferases exist that are able to transfer an adenosyl group to the 
β position of B12 as part of co-factor recycling pathways (Escalante-Semerena 
2007). CobO, however, shows greater activity towards cobyrinic-acid a,c diamide 
than towards Cbl (Debussche et al 1991).  As a prerequisite to adenosylation the 
cobalt ion must first be reduced to the supernucleophilic Co1+ species. Co(II)yrinic-
acid a,c diamide is reduced in an NADPH dependant fashion by CobR (Lawrence 
et al 2008). The activity of CobO is inhibited by HBAd, which possibly represents 
some kind of regulation of B12 biosynthesis (Debussche et al 1991).  
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The product of CobO, adenosyl-cobyrinic acid a,c diamide is the substrate for the 
second glutamine dependent amidotransferase involved in B12 biosynthesis. 
CobQ catalyses the amidation of sidechains b,d,e,g and f (Blanche et al 19911). 
The order of amidation has been determined for the CobQ equivalent from 
Salmonella enterica CbiP and found to proceed in the order e, d, b and g (Fresquet 
et al 2007). 
The final steps in the synthesis of cobalamin involve the synthesis and attachment 
of the lower nucleotide loop. The lower loop is comprised of two components 
synthesised separately from the main pathway (Roth et al 1993). The first of these 
components to be attached is the aminopropanol linker that separates the corrin 
macrocycle of B12 from the dimethylbenzimidazole (DMB) nucleotide that co-
ordinates the central cobalt ion. Aminopropanol is synthesised from threonine 
where the first step involves phosphorylation catalysed by PduX or the 
isofunctional enzyme BluF (Blanche et al 2000, Fan and Bobik 2008). This is 
followed by decarboxylation of threonine phosphate by CobC resulting in the 
formation of aminopropanol-O-2 phosphate. This linker is then attached to 
adenosyl-cobyric acid by the action of a CobD (Escalante-Semerena 2008). Both 
CobD and CobC form a high molecular weight complex in-vitro (Blanche et al 
1995).  
The second component of the lower nucleotide loop is a ribose containing 
nucleotide. In the case of the Cbl this nucleotide is DMB. Other variants of B12 exist 
in which this nucleotide is substituted for another group (Hazra et al 2013, 
Stuppperich et al 1988). In the absence of DMB a number of bacteria produce 
pseudocobalamin, here the nucleotide component of the lower loop is adenine in 
place of DMB. Interestingly when these organisms are supplemented with DMB 
they will incorporate this in preference to adenine to produce Cbl (Helliwell et al 
2016). Naturally occurring analogues of B12 exist in nature differentiated by the 
identity of the nucleotide loop attached to sidechain f, these groups include 
phenyl, benzimidazole and nucleotide substituents (Stupperich et al 1988). 
Different organisms display preferences for certain B12 analogues and will alter 
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the attached nucleotide to suit their biochemical preferences, most B12 utilising 
organisms display a preference for DMB containing cobalamins.   
DMB can be synthesised via one of two routes, an anaerobic route and better 
characterised aerobic route (Hazra et al 2015, Taga et al 2007). The starting point 
for the aerobic synthesis of DMB is Flavin mononucleotide, DMB is synthesised in 
a single O2 dependent step by BluB (Gray et al 2007). The next step in lower 
nucleotide loop biosynthesis concerns the attachment of DMB to a 
phosphoribosyl sugar derived from nicotinate mononucleotide, this is catalysed 
by CobU and results in the formation of a DMB containing nucleotide called α-
ribazole (Cameron et al 1991). 
Before the attachment of the lower nucleotide loop a guanylyl group is added to 
the terminal phosphate of Adeosyl-cobinamide phosphate by the 
guanylyltransferase CobP, this enzyme has two functions as it acts as both a kinase 
and a guanylyltransferase (Blanche et al 19912). CobP is responsible for 
phosphorylation of adenosylcobinamide as well as the attachment of GMP to the 
phosphorylated aminopropanol linker to form adenosyl-GDP cobinamide.          
The final step in B12 biosynthesis brings together GDP-cobinamide and α-ribazole 
the attachment of these two components with the subsequent loss of GDP is 












Figure 1:1:6: The terminal steps of cobalamin biosynthesis from cobalt chelation 
through to attachment of the lower nucleotide loop.  
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1:1:6 Anaerobic B12 biosynthesis 
A second pathway for B12 biosynthesis exists in nature that, in contrast to the 
previously described aerobic pathway, has no requirement for O2 (Santander et al 
1997). Biosynthesis of B12 via the anaerobic or oxygen independent route 
proceeds via cobalt insertion into the macrocycle of sirohydrochlorin by one of 
two cobalt chelatases, CbiK or CbiX (Brindley et al 2003, Schubert et al 1999). 
Despite catalysing the same reaction both CbiK and CbiX show little homology to 
one another and are highly dissimilar to the relatively complex CobNST chelatase 
utilised during aerobic B12 biosynthesis (Mendel et al 2007).   
Once cobalt is inserted into precorrin-2 the anaerobic biosynthesis of B12 broadly 
follows that of the aerobic pathway. The first step is highly similar to aerobic B12 
biosynthesis, CbiL catalyses the addition of a SAM derived methyl group to C20 in 
a reaction analogous to that catalysed by CobI in the aerobic pathway (Frank et al 
2007). Methylation at this position primes cobalt precorrin-3 for ring contraction 
through extrusion of C20 and the attached methyl group.  
Ring contraction in the anaerobic pathway relies on a different mechanism to its 
aerobic counterpart. Aerobically the mechanism of ring contraction proceeds via 
direct incorporation of oxygen at C20 to form a tertiary alcohol followed by 
rearrangement of the corrin ring to extrude C20 as an acyl group. Anaerobically 
extrusion of C20 is achieved via formation of a ɷ lactone formed between 
sidechain a and C20. This allows for the direct bonding of C1 and C19.  Ring 
contraction is catalysed by CbiH. Sidechain a of cobalt precorrin-ϯ foƌŵs a ɷ-
lactone with C20 of the corrin ring leading to its extrusion. CbiH also catalyses the 
addition of a SAM derived methyl group to C17 of the corrin macrocycle. 
Completion of these two steps yields cobalt precorrin-4 (Santander et al 1997, 
Moore et al 2013).  
CbiF, another SAM dependent methyltransferase, is responsible for the 
methylation of C11. As with the analogous methylation that occurs as part of the 
aerobic biosynthesis of B12, methylation at this position seems counter intuitive 
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as the final product has no methyl group at C11 (Schubert et al 1998, Kajiwara et 
al 2006).  
Excision of the carbon atom that began as C20 of the macrocycle of precorrin-2 is 
completed by CbiG through its removal as acetaldehyde (Kajiwara et al 2006). 
During aerobic biosynthesis these carbons are lost as acetic acid. The resulting 
intermediate, pecorrin-5b is methylated at position C1 by CbiD to form cobalt 
precorrin-6a (Moore et al 2013). As with the aerobic pathway cobalt precorrin-6a 
is more oxidised than the final product. This difference in oxidation level is 
rectified by the action of CbiJ an NADPH dependent reductase that catalyses the 
reduction of the double bond between C17 and C18 (Rossner and Scott 2006). 
During aerobic B12 biosynthesis methylation of C5 and C15 as well as the 
decarboxylation of the acetate sidechain at C12 is catalysed by a single protein 
called CobL (Blanche et al 19921). This same set of activities are encoded by two 
separate proteins in some cases when biosynthesis proceeds via the anaerobic 
route. CbiT, which shows homology to the C terminal portion of CobL catalyses 
methylation of C15 as well as the decarboxylation of C12 to produce an 
intermediate that has 7 methyl groups. An eighth SAM derived methyl group is 
attached to C5 of cobalt-precorrin-7 forming cobalt precorrin-8 catalysed by CbiE 
(Rossner et al 2006). 
The final steps before the identity of the intermediates of both B12 biosynthetic 
pathways converge are highly similar. First CbiC is responsible for the migration 
of the C11 attached methyl group to C12 catalysing a reaction analogous to that 
catalysed by CobH (Shipman et al 2001). Migration of the methyl group attached 
at C11 to C12 forms cobyrinic acid. Cobyrinic acid is then the substrate for the first 
glutamine dependent amidotransferase of the anaerobic pathway CbiA (Fresquet 
et al 2004). CbiA is analogous to CobB of the aerobic pathway and catalyses the 
amidation of sidechains a and c. Once cobyrinic acid a,c diamide is formed the 





1:1:7 Metal free corrins and metal analogues of cobalamin 
Apart from the differences in some of the earlier intermediates from the aerobic 
and anaerobic pathways the identities of the intermediates of B12 biosynthesis 
remain fixed especially the core synthesis of the corrin ring (Blanche et al 1995, 
Moore et al 2013). Some variation however, exists regarding the nature of the 
lower nucleotide loop as some oƌgaŶisŵs͛ display a preference for lower 
nucleotide loops comprised of nucleotides other than DMB (Stupperich et al 1988, 
Watanabe et al 1999). 
B12 is metabolically a costly molecule to produce, it is therefore more energetically 
favourable for organisms that require B12 to acquire the full compound or later 
intermediates of B12 biosynthesis from the environment. As B12 is present at such 
low concentrations high affinity transporters have evolved to bring B12 into cells. 
Intermediates of B12 biosynthesis are not generally found outside of cells owing 
to the metabolic cost of producing them. Additionally a mechanism by which B12 
or intermediates of B12 biosynthesis are exported from the organism that produce 
them has not be described to date. However, a number of metal free corrins had 
been isolated from the growth media of cultures of Allochromatium vinosum, 
Rhodospirillium rubrum and Rhodobacter capsulatus. Isolation of these 
compounds preceded the full elucidation of the aerobic pathway of B12 
biosynthesis (Toohey et al 1965). A majority of the extracellular-corrins isolated 
from cultures of these organisms were identified as HBAd, HBA and HBA c 
monoamide (Dresow et al 1980, Fukuzaki et al 1989). Of particular note was that 
cultures of A. vinosum produced an extracellular corrin chemically similar to B12 
but containing no cobalt (Toohey et al 1965). The identity of this cobalt free corrin 
was deduced through degradative experiments as well as by reaction with cobalt 
to produce a molecule spectrally and chromatographically identical to B12. The 
similarity of this metal free corrin to B12 resulted in it being designated 
hydrogenobalamin (Hbl), following the naming convention for its cobalt 
containing counterpart (Thomson 1969, Toohey et al 1965, Dresow et al 1980).  
Shortly after the isolation of Hbl various transition metal analogues of cobalamin 
were synthesised in a single step using Hbl as the starting material. From 1970 to 
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1980 reports regarding the synthesis of the zinc, copper, and rhodium analogues 
of cobalamin along with a brief communication describing the iron analogue of 
the B12 and various patents relating to the production of Co57 B12 from Hbl had 
been published (Bieganowski et al 1979, Charlton and Hamilton 1979, 
Koppenhagen et al 1970, Koppenhagen et al 1973). The paucity of starting 
material resulted in only small quantities of these compounds being synthesised. 
This coupled with the available analytical techniques of the time prevented a 
more rigorous characterisation of Hbl as well as the metal analogues synthesised 
from this compound. In particular little data was generated on the effects of these 
compounds with regards to biological activity. 
Due to the chemical similarity of these metal analogues to B12 they are predicted 
to interact with the uptake machinery responsible for B12 import into cells (Carmel 
et al 1977, Kräutler 2015). More recently, uptake of rhodibalamin has been 
demonstrated using a Salmonella enterica bioassay system along with a 
bactericidal effect at high concentrations (Widner et al 2016). It would be of 
interest to produce analogues of B12 that vary the central metal ion as other metal 
analogues of Cbl should also act as antagonists to B12 dependent processes and 
could therefore be considered anti-vitamins. The increased B12 requirement of 
many bacteria or of cancerous cells during proliferation relative to normal 
mammalian cells may lead to clinical application for such metal analogues of Cbl 
(Russell-Jones et al 2004). These B12 analogues may also find uses as aids to 
probing B12 dependent systems in vivo as uptake and binding of these compounds 
can be separated from the metabolic functions of B12. The differing chemical 
properties associated with various transition metal ions may also provide a 
greater understanding of the evolution of these compounds, particularly why 
nature selected cobalt as the core of B12.   
While historically Hbl was used as the starting material for the synthesis of these 
compounds the low amounts produced by cultures of A. vinosum, 1 mg of Hbl 
being isolated from 100g of cell paste (Toohey et al 1965). An alternative 
approach utilising a more abundant starting material would allow for the 
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production and characterisation of metal analogues of B12 using more modern 
analytical techniques.  
The synthesis of adenosylrhodibalamin, the rhodium analogue of adenosyl-
cobalamin was completed starting from the metal-free intermediate of B12 
biosynthesis, HBAd (Widner et al 2016). While rhodibalamin had been synthesised 
previously from Hbl (Koppenhagen et al 1970), the characterisation of this 
molecule was somewhat limited due to the small amounts of the compound it 
was possible to synthesise. The more recent synthesis of adenosylrhodibalamin 
enabled the characterisation of this molecule by X-ray crystallography and NMR 
spectroscopy along with a comparison of the data for the rhodium compound to 
that of its cobalt containing counterpart (Widner et al 2016).  
The synthesis of rhodibalamin from HBAd presents a way to more efficiently 
generate metal analogues of Cbl as HBAd can be produced at the mg scale from a 
plasmid based expression system (Deery et al 2013). The relative ease with which 
HBAd can be produced on the mg scale offsets the greater number of synthetic 
steps required to reach the final product. The synthetic scheme outlined by 
Widner et al, while an effective method for the synthesis of rhodibalamin cannot 
be adapted for the synthesis of analogues that cannot be stably adenosylated due 
to the specificity of the amidase used as part of the chemi-bio synthesis of 
adenosylrhodibalamin. In order to mimic the structure of B12 as closely as possible 
any analogues produced must harbour amide groups at positions a, b, c, d, e and 
g (Figure 1:1:2). The biosynthetic intermediate HBAd has 2 of the 6 required 
amide groups at positions a and c (Figure 1:1:6) necessitating the specific 
amidation of sidechains b, d, e and g, leaving f as a carboxylic acid.  
Following the B12 biosynthetic pathway Widner et al inserted rhodium into the 
macrocycle of HBAd to produce its rhodium analogue before this compound was 
then adenosylated and the remaining amides added by the action of Rhodobacter 
capsulatus CobQ resulting in the formation of adenoyslrhodybyric acid. The 
specificity of R. capsulatus CobQ prevents the synthesis of additional metal 
analogues due to the requirement of this CobQ for adenosylated substrates 
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(Blanche et al 19911). Therefore, in order to produce a wider variety of metal 
analogues of B12, particularly those that cannot be adenosylated an alternative 
synthetic scheme for the production of B12 analogues needs to be developed.  
The most important obstacle that needs to be overcome is to identify a means by 
which non-adenosylated metal analogues of HBAd can be specifically amidated at 
positons b, d, e and g. It is critical that sidechain f be differentiated from the other 
peripheral sidechains due to the need for nucleotide loop attachment at this 




















1:2:1 Project aims 
The aim of this project is to develop a synthetic scheme by which non-
adenosylated metal analogues of cobalamin can be produced. In doing so this 
reaction scheme could potentially be adapted to produce a number of metal 
analogues of B12 from HBAd. The main barrier to the development of such a 
synthetic scheme is a method by which sidechains b, d, e and g can be amidated 
while retaining sidechain f as a carboxylic acid group. Identification of a method 
that allows either metal containing non-adenosylated intermediates or metal free 
intermediates will broaden the scope of metal analogues that can be produced. 
As a proof of concept the zinc analogue of B12 was to be produced from HBAd. By 
undertaking this synthesis some of the intermediates produced en-route were 





















































N/A Prof B. Kräutler  
Acetonitrile  HPLC reagent grade Fisher Scientific  
Acrylamide 30% Acrylamide/Bis 
Solution, 29:1 
Bio-Rad 
Agar bacteriological N/A Oxoid 
Agarose N/A Alpha Laboratories 
Ammonium acetate ‘eageŶtPlus ≥ϵϵ.ϱ % Sigma-Aldrich 
Ammonium chloride ‘eageŶtPlus ≥ϵϵ.ϱ % Sigma-Aldrich 
Ampicillin Sodium Salt N/A Melford 
ATP ≥ϵϵ % Sigma-Aldrich 
Broad range protein marker N/A NEB 
Calcium chloride dihydrate ‘eageŶtPlus ≥ϵϵ % Sigma-Aldrich 
Chelating Sepharose Fast Flow N/A GE Healthcare 
Chloramphenicol ≥ϵϴ % Sigma-Aldrich 
Deuterium oxide 99%  
Dimethyl sulfoxide (DMSO) 99% NEB 
2-(Diethylamino)ethyl spehacel  N/A GE Healthcare 
DNA Ligase (T4) 1–3u/ʅL Promega 
DNA loading buffer (5x) N/A Bioline 
DNA Polymerase (FastStart Taq) 5 U/µl Roche 
dNTP͛s 100mM Sigma-Aldrich 
Ethanol 99.8+% analysis 
grade 
Fisher Scientific 
Ethidium bromide General purpose 
grade 
Fisher Scientific 
L-glutamine ‘eageŶtPlus ≥ϵϵ % Sigma-Aldrich 
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HEPES sodium salt Buffeƌ gƌade ≥ϵϵ % Fisher Scientific 
Hydrochloric acid 31.5-33.0% Fisher Scientific 
Hyper Ladder 1 kb DNA marker N/A Bioline 
Imidazole AC“ ƌeageŶt, ≥ϵϵ% Sigma-Aldrich 
IPTG N/A Melford 
Lichroprep RP-18  
20-ϰϬʅM paƌtiĐle size  
N/A Merck  
Methanol Analytical grade Fisher Scientific 
MgCl2 Analytical reagent 
grade 
Fisher Scientific  
NaCl 99.9+% for analysis Fisher Scientific 
Nickel(II) sulphate hexahydrate 99% analysis grade Acros Organics 
Potassium phosphate dibasic ACS reagent grade Sigma-Aldrich 
Potassium phosphate monobasic ACS reagent grade Sigma-Aldrich 
Potassium sulphate ≥ϵϵ % BDH Laboratory 
Supplies 
Restriction enzymes Variable  NEB / Promega 
Sodium acetate Reagent grade 99% Sigma-Aldrich 
Sodium dodecyl sulphate 99+% Fisher Scientific 
Sodium hydroxide ‘eageŶt gƌade ≥ϵϵ % Sigma-Aldrich 
Sodium phosphate dibasic  ‘eageŶtPlus ≥ϵϵ % Sigma-Aldrich 
Trifluoroacetic acid ‘eageŶtPlus ≥ϵϵ % Sigma-Aldrich 
Tris(hydroxymethyl) methylamine Tris buffer 99.8+% Fisher Scientific 
Tris-Acetate-EDTA 50X Fisher Scientific  
Tryptone N/A Oxoid 
Yeast extract N/A Oxoid 
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Zinc acetate dihydrate ≥ϵϵ % Sigma-Aldrich 


























2:1:2 Protein crystallography screens 
All screens were purchased from molecular dimensions Cambridge. Structure 
screen 1 was used for initial screening (Wooh et al 2003). Additional screens were 
conducted using Molecular dimensions Midas screen (Grimm et al 2010)  
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2:1:3 Escherichia coli strains 




endA1, recA1, gyrA96, thi, hsdR17 (rk–, 
ŵk+Ϳ, ƌelAϭ, supEϰϰ, Δ;laĐ-pƌoABͿ, [F′, 
tƌaDϯϲ, pƌoAB, laƋIƋ)ΔMϭϱ] 
 
Promega 
BL21 (DE3) F– ompT hsdSB (rB– mB–) gal dcm 
(DE3) 
Novagen 
BL21 (DE3) pLysS F- ompT hsdSB(rB- mB-) gal dcm (DE3) 
pLysS (CamR) 
Novagen 




























pET-AvCobQ pET14b-AvCobQ Protein overexpression vector 
containing N-terminal polyhistidine-
tag Allochromatium vinosum CobQ 
pET14b-
RcCobQ 
pET14b-RcCobQ Overexpression vector containing 
N-terminal polyhistidine-tag 




pET14b-CobB Overexpression vector containing 
N-terminal polyhistidine-tag 
Rhodobacter capsulatus CobB (Dr 
Evelyne Deerey) 
pET14b-BtuF pET14b-BtuF Overexpression vector containing 
N-terminal polyhistidine tagged 
Escherichia coli BtuF 
pET3a-HBAd pET14b-HBAd Overexpression vector containing 
the cobalamin biosynthetic genes 












Overexpression vector containing 
the cobalamin biosynthetic genes 
AIGJFMKLHBQ kindly donated by Dr 
Emi Nemoto-Smith 







































Glassware was purchased from SCHOTT and Fisher. 
Micro-centrifuge tubes were purchased from Eppendorf. 
50ml falcon tubes were purchased from SARSTEDT 
Millipore water was dispensed from a Simplicity 185 device with a Simpak 1 
cartridge.  
Solutions and equipment were autoclaved using a Priorclave 40 benchtop 
autoclave. 121 °C at 1 bar pressure for 15 minutes 
Centrifugations were performed with the following centrifuges and rotors: 
Beckman Coulter Avanti J-30I    
-JLA_9.100 
-JA_25.50 
ALC, Multispeed refrigerated centrifuge   
-T527 
Thermo Scientific, Megafuge 16R   
-TX-400 
Eppendorf, MiniSpin Plus    
-F45-12-11 
 
Polymerase chain reactions were carried out in an Eppendorf Mastercycler 5341 
thermal cycler. 
 
DNA Electrophoresis was performed with a PerfectBlue Gel System Mini M 
(Peqlab) and a Bio-Rad PowerPak 300. DNA was visualised with a UVIsave HD5 
device from UVItec. 
 
Sonications were performed with a Sonics vibracell sonicator equipped with a 
Jencons solid titanium alloy probe. 
 
Buffer exchange of proteins was performed with PD-10 size exclusion columns 




Protein electrophoresis was performed with an Atta Mini Power Electrophoresis 
Power Supply, SJ-1082. 
 
All UV-vis measurements were performed using an Agilent Cary 60 UV/ Vis with 
semi micro UV cuvettes from Brand or quartz crystal cuvettes, 1.5-3 ml path 
length 1 cm. 
 
NMR spectra were collected using 600 MHz: Bruker Ultrashield spectrometer or 
a 500 MHz: Varian Unity Inova 500. Spectra were collected at 298K referenced 
agaiŶst HDO ɷ = ϰ.ϳϵ ppŵ for both D2O and 10% D2O 90% H2O solvent systems.  
1D-1H spectra for Hby, Zby and Zbl recorded in D2O used a presat pulse program. 
2D-1H homonuclear COSY and ROESY spectra for Zby and Zbl were recorded using 
a gCOSY and ROSEYAD pulse programs respectively. 2D-1H, 13C heteronuclear 
HSQC experiments for Zby and Zbl were recorded using a gHSQC pulse program. 
These experiments were recorded using a 500 MHz Varian Unity Inova 500. 
The 1D-1H spectrum of Hby recorded in 90% H2O 10% D2O was produced using a 
Watergate-zgesgp pulse program for solvent suppression. A 2D-1H ROESY 
homonuclear run in 90% H2O 10% D2O was recorded using a ROESYesgpph pulse 
program for suppression of the water peak. A 2D-1H 13C heteronuclear HSQC 
recorded in 90% H2O 10% D2O was produced using a HSQCetfpgpsi2 pulse 
program for suppression of the water peak. These spectra were recorded on a 
Bruker Ultrashield 600 MHz spectrometer.   
 
Fast protein liquid chromatography (FPLC) was conducted using an Äkta FPLC 
system; P-920 pump, UPC-900 monitor for UV detection at 280 nm. Analyses were 
performed using a Superdex G200 size exclusion column able of separating 
protein complexes between 10 KDa and 600 KDa. 
 
High performance liquid chromatography (HPLC) was performed using an Agilent 
1100 HPLC system with diode array detector. Analyses were conducted using an 
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ACE chromatography 5AQ column 150 mm x 2.1 mm 5 ʅM paƌtiĐle size. AdditioŶal 
chromatography was performed using a Hitachi HPLC system, L-2130 pump with 
online degasser and diode array detector (Phenomenex hyperclone C18, 250 mm 
x 4.6 mm). 
Mass spectra were collected using a Finigan MAT 95s LCQ classic electrospray 
mass spectrometer. Additional spectra were collected using a Bruker micro Qtof 
II with electrospray ionisation. 
 

























2:1:7 Solutions for molecular biology work 
Molecular weight marker 
Hyper Ladder 1 kb DNA Marker: 
 
Figure 2.1.1 Hyper Ladder 1 kb DNA Marker run on a 1% agarose gel (Bioline, MA) 
 
Ligation buffer. 
60 mM Tris pH7.8 
20 mM MgCl2 
20 mM DTT 
2 mM ATP 













2:1:8 Media and solutions for microbiological work 
Lysogeny broth (LB) 
NaCl   86.2 mM 
Yeast extract  5 g/L 
Tryptone  10 g/L 
Diluted in dH2O before autoclaving (121 °C 3 bar pressure for 15 minutes) 
2YT + Ammonium acetate  
Ammonium acetate  13 mM 
NaCl   86.2 mM 
Yeast extract  10 g/L 
Tryptone  16 g/L 
Diluted in dH2O before autoclaving (121 °C 3 bar pressure for 15 minutes) 
 
Lysogeny broth agar (LB agar) 
Add 15 g of bacteriological agar to 1 L of LB 
 
10X M9 salts 
Na2HPO4  478 mM 
KH2PO4  222 mM 
NH4Cl   187 mM 
NaCl  86.2 mM 
Diluted in dH2O before autoclaving (121 °C 3 bar pressure for 15 minutes) 
 
0.1M CaCl2 
Made up ǁith ŵilliQ filteƌed ǁateƌ aŶd filteƌ steƌilised, Ϭ.Ϯ ʅŵ filteƌ. 
 
1M MgSO4 
Made up ǁith ŵilliQ filteƌed ǁateƌ aŶd filteƌ steƌilised, Ϭ.Ϯ ʅŵ filteƌ. 
 
20% w/v D-glucose 





Made up with ŵilliQ filteƌed ǁateƌ aŶd filteƌ steƌilised, Ϭ.Ϯ ʅŵ filteƌ. 
 
L-methionine 5mg/ml 
Made up ǁith ŵilliQ filteƌed ǁateƌ aŶd filteƌ steƌilised, Ϭ.Ϯ ʅŵ filteƌ. 
 
M9 minimal media 
Minimal media was made up as follows in a container sterilised by autoclave. 100 
ml of 10X M9 salts, 20 ml 20% w/v glucose 2ml of MgSO4 1ml of CaCl2 10 ml of 5 
mg/ml cysteine the solution was made up to 1 L with H2O sterilised by autoclave. 
 
Minimal media agar supplemented with methionine and cysteine 
100 ml of 10X M9 salts, 20 ml 20% w/v glucose 2ml of MgSO4 1ml of CaCl2 10 ml 
of 5 mg/ml cysteine and 10 ml 5 mg/ml methionine  the solution was made up to 
1 L with 900 ml H2O ĐoŶtaiŶiŶg ϭϱ g of agaƌ at ϰϱ⁰ C 
 
Salmonella bioassay plates 
Minimal media Agar was made up using 100 ml 10X M9 salts, 20 ml 20% w/v 
glucose 2ml of MgSO4 1ml of CaCl2 10 ml of 5 mg/ml cysteine. The Final volume 
was adjusted to 1 L with 900 ml H2O containing 15 g agar at 40°C. A lawn of 
Salmonella enterica (AR2680 cysG, cbiB) was scraped from minimal media plates 
containing both cysteine 0.05 mg/L and methionine 0.05 mg/L. Salmonella was 
washed in 0.9% w/v NaCl before being added to the bioassay agar at 40°C. Plates 











Stock concentration: 100 mg/ ml in H2O. Filteƌ steƌilised Ϭ.Ϯʅŵ filteƌ, ǁoƌkiŶg 
ĐoŶĐeŶtƌatioŶ ϭϬϬ ʅg/ ŵl 
 
Chloramphenicol   
Stock concentration: 34 mg/ ml in ethanol, working    ĐoŶĐeŶtƌatioŶ: ϯϰ ʅg/ ŵl 
Antibiotics were stored at -20 °C until use. 
 
Calcium chloride (0.1 M) + 10% glycerol  
CaCl2.2H2O + 10% glycerol made up with H2O aŶd filteƌ steƌilised ;Ϭ.Ϯ ʅŵͿ 
 
IsopƌopǇl β-D-1-thiogalactopyranoside (IPTG) (1 M) 




















2:1:9 Solutions for biochemical work 
NaCl solution (5 M) made up with H2O 
Tris-HCl solution (1 M) made up with H2O and adjusted to pH 8.0 with 
concentrated HCl 
Imidazole solution (1 M) made up with H2O 
Nickel sulphate (100 mM) made up with H2O 
4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES) solution (100 mM) 
made up with dH2O 
Ammonium acetate (10mM) made up with H2O  
Running buffer for SDS-PAGE: 
25 mM Tris-HCl  






















Prestained Protein Marker, Broad Range (7-175 kDa) 
 
Figure 2.1.2 Prestained Protein Marker, Broad Range (7-175 kDa) run on a 10-20% 
Tris-glycine SDS-PAGE gel (New England Biolabs, MA) 
 
2X Laemmli sample buffer: 
0.125 M Tris-HCl pH 6.8 
20% v/v Glycerol 
4% w/v SDS 
10% v/v β-mercaptoethanol: 
0.004% w/v Bromophenol blue 
 
Coomassie blue stain: 
250 ml Trichloroacetic acid (TCA) (100%) 
0.73 mM Coomassie brilliant blue 
0.35 mM SDS 
2 mM Tris 





Solutions for immobilised metal ion affinity chromatography (IMAC) 
Binding buffer: 
20 mM Tris-HCl, pH 8.0 
500 mM NaCl 
5 mM Imidazole 
 
Wash buffer 1: 
20 mM Tris-HCl, pH 8.0 
500 mM NaCl 
50 mM Imidazole 
 
Wash buffer 2: 
20 mM Tris-HCl, pH 8.0 
500 mM NaCl 
100 mM Imidazole 
 
Elution buffer:  
20 mM Tris-HCl, pH 8.0 
500 mM NaCl 
400 mM Imidazole 
 
FPLC running buffer: 
20 mM Tris-HCl, pH 8.0 










2:2 Molecular biology methods 
2:2:1 PCR amplification of genes 
Amplification of A. vinosum CobQ by PCR. A sterile PCR tube was set up with the 
following reagents: 
PCR-A Stock concentration Volume (µl) 
PCR reaction buffer with 
20mM MgCl2 
10X 5 
Template DNA N/A 1 
FW primer 10 µM 2 
Rev Primer 10 µM 2 
FastStart Taq DNA 
Polymerase 
5 U/µl 0.5 
dNTP͛s 5 mM 2 
DMSO N/A 1 
Autoclaved H2O N/A 37.5 
 Table 2.5 PCR reaction mixture  
 
The PCR reaction was run in a thermocycler using the following program: 
Step Time Temperature Cycles 
1 60 sec 94 °C  
1-3 repeat  
20 times 
2 60 sec 50 °C 
3 1 min 30 sec 72 °C 
4 1 min 94 °C 1 
5 10 min 72 °C 1 
6 Hold 4°C - 
Table 2.7 PCR reaction cycles for PCR1-A and PCR1-B 
PCR products were run on a 1% agarose gel, bands were cut out and gel extracted 






2:2:2 Analysis of DNA by gel electrophoresis  
DNA fragments were separated in a 1% agarose gel run in 1X TAE buffer, DNA was 
ǀisualised ǁith ethidiuŵ ďƌoŵide at a fiŶal ĐoŶĐeŶtƌatioŶ of Ϭ.ϱ ʅg/ŵl. Pƌioƌ to 
loading DNA was mixed with 5X loading buffer. 
 
2:2:3 Gel extraction of DNA 
DNA was extracted from agarose gels and from PCR clean-up reactions using a 
QIAquick Gel Extraction Kit (Qiagen), according to the handbook 
 
2:2:4 Restriction digests 
DNA was digested in a total reaction volume of 10 ʅl in a sterile 1.5 ml 
Eppendorf with appropriate enzymes and reaction buffers.  Reactions were 
incubated at 37 °C for 2 hours. 
Typical restriction digest protocol: 
Plasmid DNA, 5 µl 
Restriction enzyme 1, 0.5 µl  
Restriction enzyme 2, 0.5 µl 
10X Buffer, 1 µl 
H2O, 3 µl 
 
2:2:5 DNA Ligations 
DNA fragments were ligated in 10 ʅl reactions in sterile 1.5 ml Eppendorf tubes. 
Typical ligation protocol: 
Vector, 1.5 µl 
Insert, 2.5 µl 
2 X ligation buffer, 5 µl 
T4 DNA ligase, 1 µl 
 
2:2:6 Purification of plasmid DNA 
Plasmid DNA was purified using a QIAprep Spin Miniprep Kit (Qiagen) according 
to the handbook 
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2:3 Microbiological methods 
 
2:3:1 LB Agar plates 
Bacteria were applied to LB agar plates with appropriate antibiotics. Agar plates 
were incubated overnight at 37 °C. 
 
2:3:2 LB Liquid cultures 
Liquid cultures were inoculated 1:100 from overnight starter cultures, with 
appropriate antibiotics and grown at 37 °C with shaking (160 rpm). 
 
2:3:3 Cultures for production of HBAd and Hby 
BL21(DE3) expressing pET3a-Hby or pET3a-HBAd were used to inoculate 1 l of 2YT 
with 1 g/l ammonium acetate. Cells were grown in 2 l borosilicate baffled flasks 
at 28°C for 36 hours with shaking at 120 RPM.   
 
2:3:4 Competent cells 
50 ml of LB was inoculated with 5 colonies; cells were grown at 37 °C with shaking 
to an OD600 of ~ 0.7. Cells were cooled on ice for 10 minutes then centrifuged at 
2,700 x g for 10 minutes at 4°C. Pelleted cells were resuspended in 10 ml 0.1 M 
CaCl2 + 10% glycerol and stored on ice for 15 minutes. Following centrifugation 
at 2,700 x g for 10 minutes at 4 °C the supernatant was removed and the cells 
were resuspended in 1 ml 0.1 M CaCl2 + 10% glycerol. Cells were then aliquoted 












3 ʅl of plasmid DNA was added to 30 ʅl of competent cells for single 
transformations, for double transformations 1.5 ʅl of each plasmid was used. The 
cells were incubated on ice for 15 minutes, they were then heat shocked at 42 °C 
for 1 minute then incubated on ice for a further 2 minutes. 200 ʅl of LB was then 
added, cells were incubated at 37 °C for 20 – 60 minutes. Cells were subsequently 
plated on LB agar plates with appropriate antibiotics and incubated overnight at 
37 °C. 
 
2:3:6 Overexpression of recombinant protein 
BL21 (DE3) pLysS competent cells were transformed with a plasmid containing 
the gene(s) of interest and plated on LB agar plates and incubated overnight at 37 
°C. 10 ml of LB was inoculated with colonies from the transformation plate and 
appropriate antibiotics. 1 l LB in baffled flasks was inoculated with the overnight 
starter culture with appropriate antibiotics. The cultures were grown at 37 °C with 
shaking for 7 hours; protein production was induced by the addition of IPTG to a 
final concentration of 400 mM. The cultures were then incubated overnight at 19 
°C with shaking. Cells were harvested by centrifugation at 3320 x g for 15 minutes 
at 4 °C, pellets were resuspended in binding buffer.   
 
2:3:7 Production of HBAd and Hby in E.coli 
BL21 (DE3) pLysS competent cells were transformed with a plasmid containing 
either the cobalamin biosynthetic genes AIGJFMKLHB (pET3a-HBAd) or 
AIGJFMKLHBQ (pET3a-Hby) and plated on LB agar plates containing 0.5% w/v 
glucose and incubated overnight at 28 °C. 10 ml of LB was inoculated with colonies 
from the transformation plate and appropriate antibiotics. 1 l 2YT supplemented 
with 1 g/l ammonium acetate in baffled flasks was inoculated with the overnight 
starter culture with appropriate antibiotics. The cultures were grown at 28 °C with 
shaking for 24 hours. Cells were harvested by centrifugation at 4000 x g for 20 




2:3:8 Salmonella bioassay plates 
Salmonella typherium ΔCďiB ΔCǇsG ǁas gƌoǁŶ iŶitiallǇ as a lawn on M9 minimal 
media plates supplemented with 0.05 mg/l L-cysteine and L-methionine. 
Salmonella was scraped from the surface of a 92mm diameter agar plate using a 
sterile loop. Salmonella was resuspended in 0.9% NaCl and pelleted by 
centrifugation at 2500 x g for 2 minutes this process was repeated 3 times. 
Salmonella was added to M9 minimal media agar without methionine at 40 °C, 
Salmonella was distributed throughout the agar by swirling before plates were 
poured and left to set. In order to test the biological activity of hydrogenobyrinic 
and zincobyric acid 5 ʅl of these compounds at various concentrations was 
dropped onto the surface of the plates and allowed to adsorb into the agar before 
the plate was incubated at 37°C for 15 hours.  
 
2:3:9 Plate ƌeadeƌ ƌeĐoƌded gƌoǁth of “alŵoŶella ΔCďiB ΔCǇsG 
Salmonella typherium ΔCďiB ΔCǇsG ǁas gƌoǁŶ iŶitiallǇ as a laǁŶ oŶ Mϵ ŵiŶiŵal 
media plates supplemented with 0.05 mg/l L-cysteine and L-methionine. 
Salmonella was scraped from the surface of a 92 mm diameter agar plate using a 
sterile loop. Salmonella collected in this way was used to inoculate 100ml M9 
minimal media giving a final OD of 0.1. 1 ml of inoculated media was transferred 
to one of 24 wells containing various concentrations of Hby and B12. The cultures 
were incubated with shaking in a Fluostar omega plate reader at 37°C OD 600 
measurements were recorded at 600 nm every 10 minutes. Each growth 











2:4 Cell lysis  
Cells were lysed by one of two methods outlined below: 
 
2:4:1 Sonication  
Cell pellets resuspended in binding buffer were sonicated for 5 minutes with a 30 
second pulse at an amplitude of 65%. Followed by 30 seconds with no pulse. 
sonications were performed on ice.  
 
2:4:2 Boiling water bath  
Cell pellets expressing plasmids pET3a-HBAd and pET3a-Hby resuspended in H2O 























2:5 Biochemical methods 
 
2:5:1 Immobilised metal ion affinity chromatography (IMAC) 
Preparation of nickel ion affinity column  
Add a filter to an empty column and load with 5 ml of Chelating Sepharose Fast 
Flow, wash column with dH2O.The column was charged with 10 ml of 100 mM 
NiSO4 and equilibrated with 20 ml binding buffer.  
Immobilised nickel ion affinity chromatography 
Following cell lysis, cell debris was removed by centrifugation at 39,191 x g for 20 
minutes at 4 °C. The supernatant was applied to the column and then column was 
then washed with 20 ml of binding buffer, followed by 10 ml of wash buffer 1. The 
column was then washed with 10 ml of wash buffer 2. Proteins of interest were 
eluted with 15 ml of elution buffer and 1 ml elution fractions were collected. 
 
2:5:2 Buffer exchange 
Following IMAC 625 ʅl of the four strongest elution fractions (determined by 
Bradford assay) were loaded onto a PD-10 desalting column equilibrated in 
exchange buffer and allowed to flow through. The protein of interest was eluted 















2:5:3 Fast protein liquid chromatography (FPLC) 
The protein solution, depending on the size of the protein, was loaded onto a pre-
packed, high resolution Superdex 10/300 G200 column, equilibrated with 1.5 - 2 
column volumes of FPLC buffer. The protein was eluted at 0.5 ml/min into 1 ml 
fractions with buffer on an Äkta FPLC chromatography system with in line UV light 






















Figure 2:5:1: Calibration curve for Superdex G200. A number of proteins of known 
molcuelar weight were applied to the colmn and the retention times recored the void 
volume of the column (8.6) was determined by the addition of blue dextran (MW 
2000000 KDa). The log MW of the standard proteins were plotted against their elution 
volume (Vo) divided by the void volume of the column (Ve). A linear fit for this data 
gave the equation log MW = (Vo/Ve) * -1.42 +7.44.  
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2:5:4 Determination of protein concentration  
Protein concentrations were determined by measuring absorbance at 280 nm in 
cuvette with a path length of 1 cm. A blank is set using 1 ml of exchange buffer. 
The molar extinction coefficient (ɛ) was calculated using the EXPASY protparam 
bioinformatics tool (Gasteiger et al 2005). Protein concentrations were calculated 
using the Beer Lambert law A = ɛCL, where A is absorbance, C is the molar 
concentration and L is the path length. 
 
2:5:4 In-vitro synthesis of Hby 
HBAd was incubated with N-terminal polyhistidine tagged A.  vinosum CobQ (0.64 
ʅMͿ, puƌified ďǇ ŶiĐkel affiŶitǇ ĐhƌoŵatogƌaphǇ. Was ŵiǆed ǁith a solutioŶ of 
HBAd ;Ϯϳ.ϯ ʅMͿ, ϮϬ ŵM Tƌis pH ϴ.Ϭ, ϮϬϬ ŵM NaCl ϭ ŵM ATP aŶd ϯŵM glutaŵiŶe. 
The reaction mixture was protected from light and incubated at 28°C for 15 hours.  
 
2:5:5 Analysis of recombinant proteins by gel electrophoresis 
Protein samples were collected mixed with 2X Laemmli sample buffer and boiled 
for 10 minutes. 
 
Polyacrylamide gels were set up as outlined below: 
Resolving gel 12.5% Stacking gel 5% 
H2O (ml) 3.4 H2O (ml) 3.4 
30% Acrylamide 
(ml) 
6.3 30% Acrylamide 
(ml) 
1.5 
1.5M Tris-HCl pH 
8.8 (ml) 
3.8 0.5M Tris-HCl pH 
6.8 (ml) 
1.9 
10% SDS (ml) 1.5 10% SDS (ml) 0.75 
10% APS (ml) 0.15 10% APS (ml) 0.075 
TEMED (ml) 0.01 TEMED (ml) 0.01 




Gels were run in running buffer at 200 volts for 1 hour and stained with coomassie 
blue stain. Gels were de-stained overnight in H2O under gentle agitation.  
2:5:6 Protein crystallography 
A. vinosum CobQ was concentrated to 8 mg/ml and used to generate protein 
crystals by hanging drop diffusion. 1 ʅL CobQ solution (8 mg/ml CobQ 20 mM tris 
pH 8.0 200 mM NaCl) was mixed with 1 ʅL of each of the precipitants on a 
siliconized glass cover slip the resulting drop was inverted over 1 ml of the 
precipitant condition and the experiment was allowed to stand for 3 days at 20 









Figure 2:5:2: Schematic representation of hanging drop vapour diffusion experiment 
by which crystals of CobQ were generated. 1 μl of CobQ at a concentration of 8 
mg/ml was mixed with 1 μl precipitant. This drop was inverted over 1 ml of the 
precipitant solution and incubated for 3 days at 20 ⁰C                                                                 
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2:6 Chromatographic methods 
 
2:6:1 Weak anion exchange chromatography of HBAd 
Extraction of HBAd from cells expressing pET3a-HBAd cell pellets were lysed by 
boiling water bath. Precipitated protein was removed by centrifugation at 
32,000xg for 15 minutes the supernatant was retained and the pellet 
resuspended in 25 ml 10 mM ammonium acetate before centrifugation at 
36,000xg. The supernatant was combined with the supernatant from the previous 
step and applied to DEAE resin equilibrated in 10mM ammonium acetate. Once 
bound the resin was washed with 2 column volumes of 10 mM ammonium 
acetate. Additional washes consisted of 1 column volume each of 10 mM 
ammonium 100 mM NaCl and 10 mM ammonium acetate 150 mM NaCl. HBAd 
was eluted with 10 mM ammonium acetate 250 mM NaCl. 
 
2:6:2 Reverse Phase chromatographic separation of Hby 
Hby was purified by reverse phase chromatography either from cells expressing 
pET3a-Hby lysed by boiling water bath and precipitated protein removed by 
centrifugation at 36,000 x g for 20 minutes. Alternatively from Hby produced in-
vitro from HBAd and recombinantly produced A. vinosum CobQ the reaction 
mixture was clarified by centrifugation at 36,000 x g for 20 minutes. The 
supernatant was applied to Lichroprep RP-18 resin equilibrated in 10 mM 
ammonium acetate. The resin was washed with 2 column volumes of 10 mM 
ammonium acetate. The resin was washed with 1 column volume each of 10 mM 
ammonium acetate 10 % v/v methanol and 10mM ammonium acetate 20 % v/v 









2:6:3 HPLC analysis of Hby 
HPLC analysis of Hby using an Agilent 1100 HPLC system using an ACE 
chromatography 5 AQ C18 column samples were analysed using 0.1% v/v TFA  in 
H2O and acetonitrile as the organic phase. Samples were analysed using a 0 - 100% 
acetonitrile gradient over 40 minutes.  
Additional HPLC analysis of Hby was performed on a Hitachi L-2130 pump system 
using a Phenomenex hyperclone 250 reverse phase C18 column. Analyses were 
performed with 10mM ammonium acetate as the aqueous phase and acetonitrile 
as the organic phase. The following gradient was used to separate Hby 0-5 
minutes up to 5% acetonitrile 5-40 minutes up to 20% acetonitrile 40-45 minutes 
up to 5% acetonitrile.  
 
2:6:4 HPLC analysis of Zby, Zbl and Hbl 
Zincobyric acid was analysed by HPLC using a Hitachi L-2130 pump system using a 
Phenomenex hyperclone 250 reverse phase C18 column. Analysis were 
conducted using a 10mM ammonium acetate in H2O as the aqueous phase and 
acetonitrile as the organic phase. The following gradient was used 0-5 minutes up 
to 10% acetonitrile 5-40 minutes up to 16% acetonitrile. UV chromatograms were 
collected using the in line diode array detector. 
 
2:6:5 HPLC standards 
HBA monoamide, HBAd and Hby retention times for these compounds when 
analysed using Agilent 1100 HPLC system and an ACE chromatography 5AQ C18 
column and a 0.1 % TFA, acetonitrile gradient were determined by mass 
spectroscopy on account of a Bruker Qtof II electrospray mass spectrometer in 
line.  
Retention times for Hby, Zby, Hbl and Zbl when analysed using a Hitachi L-2130 
pump system and phenomenez hyperclone 250 C18 column using a 10 mM 
ammonium acetate, acetonitrile gradient were determined by comparsion to 
standard solutions of these compounds. Retention times are as follows, Hby 30.8 
minutes, Zby 31.4 minutes, Hbl 37.5 minutes and Zbl 39 minutes. 
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2:7:1 Chemical synthesis 
 
2:7:2 Synthesis of zincobyric acid  
6.93 mg of hydrogenobyric acid is mixed with 34 mg (20 equivalents) of zinc 
acetate and 2.6 mg (4 equivalents) of sodium acetate the mixture is dissolved in 
10 mL of H2O degassed with argon. The mixture was heated to 50 °C for 1 hour 30 
minutes before the reaction was stopped by binding the material to a Se-Pak 
column (1 g, C18 Waters) equilibrated in water and desalted by washing with 40 
mL of H2O the zincobyric acid was eluted in methanol and dried by rotary 
evaporation (30 °C  at 120 mbar pressure). Zby produced in this was further 
purified by reverse phase chromatography on the bench. The material was bound 
to lichroprep RP-18 resin equilibrated in 10mM ammonium acetate buffer at pH 
7.0, the material was bound to the resin in the same buffer before being washed 
with 10% methanol in 10 mM ammonium acetate buffer pH 7.0. The column as 
further washed with 3 column volumes of 15% v/v methanol in 10 mM 
ammonium acetate buffer. Zby was eluted with 20% methanol in 10 mM 
ammonium acetate buffer pH 7.0. Zby was dried by rotary evaporation to remove 
methanol and desalted over Se-Pak. Zby was dried by rotary evaporation before 
precipitation of the material using water acetone. Zby was dissolved in 500 ʅl H2O 
and acetone added to a total volume of 10 ml the mixture was incubated at 4 °C 
for 2 hours before the acetone was removed the precipitate was washed with 
fresh acetone at 0 °C before the precipitate was dried in-vacuo overnight. 7.02 mg 
of zincobyric acid was synthesised in this way giving a yield of 95%.  
 
2:7:3 Synthesis of Zbl  
4.71 mg of zincobyric acid was mixed with 2.21 mg (1.2 equivalents) of lower 
nucleotide loop along with 2.3 mg (2 equivalents) of hydroxybenzotriazol. 
Reactants were dissolved in 2.5 ml H2O and stirred at room temperature under 
an argon atmosphere. 9.3 mg (9.4 equivalents) of 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide hydrochloride (EDC*HCl) was dissolved in 
500 ʅl H2O. The two solutions were mixed under an argon atmosphere and stirred 
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at room temperature for 4 hours. Previous syntheses began stirring at 0 °C for two 
hours before stirring for 4 hours at room temperature. The reaction was stopped 
by binding the material to Lichroprep RP-18 resin equilibrated in 10 mM 
ammonium acetate the resin is washed with 10 % acetonitrile followed by 15 % 
acetonitrile in 10mM ammonium acetate buffer at pH 7.0. Zbl was eluted in 30 % 
acetonitrile. Acetonitrile was removed by rotary evaporation and the Zbl was 
desalted by Se-pak and eluted in methanol and dried by rotary evaporation. 6.62 





















Chapter 3: Isolation and characterisation of 














One of the more challenging aspects regarding the synthesis of metal analogues 
of B12 from HBAd is the specific amidation of the peripheral sidechains. As part of 
the biosynthesis of B12 the carboxylic acid sidechains decorating the corrin ring 
are converted to amides aside from sidechain f, which is retained as a carboxylic 
acid until nucleotide loop attachment (Blanche et al 1995, Warren et al 2002).  
While it is possible to amidate these groups by chemical means the need to retain 
sidechain f as a carboxylic acid requires a more specific method. The synthesis of 
adenosylrhodibalamin reported by Widner and co-workers used the enzyme 
responsible for the amidation of these sidechains in-vivo to produce 
rhodibalamin. The recombinantly produced CobQ used in the study by Widner et 
al was a R. capsulatus derived enzyme and is specific for substrates that harbour 
an upper adenosyl group (Blanche et al 19911, Widner et al 2016). This 
methodology is therefore unsuitable for the synthesis of an expanded range of 
metal analogues due to the requirement for adenosylated substrates.  
A second route by which metal analogues of B12 have been synthesised is the 
direct incorporation of a metal ion into the corrin ring of Hbl (Bieganowski et al 
1979, Koppenhagen et al 1970, Koppenhagen et al 1975). This red metal-free 
corrin was shown to be produced by cultures of A. vinosum when grown in cobalt 
deficient media (Toohey et al 1965). Later experiments in which cultures of A. 
vinousm were supplemented with the nucleotide dimethylbenzimidazole (DMB) 
resulted in the formation of a compound that was shown to be identical to that 
of B12 but contained no cobalt (Koppenhagen and Pfiffner 1971). Determination 
of the structure of hydrogenobalamin was achieved through degradative 
experiments and comparison of the fragments with those of B12 treated in the 
same way. The structures of HBA, HBAd and Hbl are shown alongside the 







Figure 3:1:1 Structures of hydrogenobalamin (Hbl), cobalamin, hydrogenobyrinic 






The isolation of Hbl led to the synthesis of various analogues of B12 that varied the 
central metal ion. These analogues were produced from Hbl through the insertion 
of zinc, copper and rhodium (Koppenhagen et al 1971, Koppenhagen et al 1970). 
A brief report describing the synthesis of an iron analogue of B12 was published 
later (Bieganowski et al 1979). Hbl represents an appealing starting point for the 
synthesis of metal analogues as it allows for the synthesis of the desired analogue 
in a single step. However, hydrogenobalamin is produced only in small quantities 
from wild type bacteria such as A. vinosum, Rhodospirillum rubrum and 
Rhodobacter spheroides (Toohey 1974). Hence, alternative methods need to be 
developed for production of larger amounts of these analogues.  
The driving force behind the isolation of Hbl was the ability for this compound to 
be easily transformed into a number of metal analogues of B12 by chemical metal 
insertion. Access to a number of different B12 analogues that have none of the 
associated metabolic functions of B12 would allow these compounds to be used 
as tools to probe the mechanism of a number of B12 dependent enzymes. More 
recently the synthesis of the rhodium analogue of B12 was achieved starting from 
the aerobic biosynthetic intermediate HBAd (Widner et al 2016).  
The two methods described in the literature relating to the synthesis of metal 
analogues are limited either by the availability of suitable starting material, as is 
the case for methods using hydrogenoabalamin, or by the specificity of CobQ in 
the case of the synthesis of rhodibalamin from HBAd. Therefore, in order to 
expand the range of metal analogues of B12 that can be produced from HBAd a 
CobQ that amidates HBAd rather than adenosylcobyrinic acid a, c diamide needs 
to be identified. A good starting point for the isolation of such an enzyme is the ɶ 
proteobacterium A. vinosum, which has been reported in the literature as 
producing the metal free analogue of B12 (Toohey et al 1965). It follows that as 
hydrogenobalamin has the same pattern of amides as cobalamin the enzyme 
responsible for adding these groups, CobQ will recognise metal free substrates. 
A. vinosum CobQ is therefore a promising candidate for an amidase that has the 
ability to recognise substrates that contain no central metal ion or upper adenosyl 
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group. Isolation of such an amidase will allow for the production of a wider range 
of B12 analogues. 
The work presented in this chapter concerns the identification of a CobQ that is 
able to amidate a metal free intermediate of B12 biosynthesis, HBAd. In identifying 





















3:2:1 cloning and expression of A. vinosum CobQ  
The genome of A. vinosum has been fully sequenced and the genomic data 
deposited into a number of databases (Weissgerber et al 2011). Annotation of the 
genome of A. vinosum shows this organism has a single gene annotated as cobQ 
within the genome. Primers were designed flanking the entirety of this gene, 
introducing an NdeI and SpeI restriction site upstream and downstream of the 
gene respectively. PCR was used in order to amplify this gene (Method 2:2:1). The 
fragment generated was ligated into a pET14b plasmid to form the plasmid 
pET14b-AvQ. This vector provides an expression platform that allows the gene 
product to be produced with an N-terminal hexahistidine tag. This plasmid was 
transformed into E. coli BL21-DE3 containing an additional pLysS plasmid, 
encoding lysozyme and maintained by a chloramphenicol resistance gene 
(Method 2:3:6). The expression strain was used to produce N-terminally 
hexahistidine tagged CobQ, allowing the protein to be purified initially by nickel 
affinity chromatography (Method 2:5:1). SDS page analysis of the fractions 
produced as a result of nickel affinity chromatography was performed and the 












Analysis of the fractions collected from nickel affinity chromatography shows that 
A. vinosum CobQ can be produced recombinantly and isolated to a reasonable 
degree of purity. Further analysis of isolated A. vinosum CobQ was conducted by 
size exclusion chromatography, the elution profile from this experiment is show 
in Figure 3:2:2.  
 
 
Figure 3:2:1: Analysis of fractions from the nickel affinity chromatography of A. 
vinosum CobQ predicted mass 56 kDa and R. capsulatus CobQ predicted mass 50 
kDa. As analysed by denaturing polyacrylamide electrophoresis. FT corresponds to 
material not bound to the column upon application of supernatant. W2 and W3 
correspond to washing the column with 20 mM Tris pH 8.0 containing 500 mM NaCl 
and 50 mM imidazole (W2) or 100 mM imidazole (W3). Eluted A. vinosum CobQ is 
















Figure 3:2:2 Size exclusion chromatogram of A.vinosum CobQ as initially 
purified by nickel affinity chromatography. The first elution peak corresponds 
to CobQ aggregate with a molecular mass of approximately 877 kDa. The 
large peak with a molecular mass of approximately 214 kDa corresponds to a 






























Retention  volume  (ml)
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3:2:3 Reaction of CobQ with HBAd 
CobQ is an amidase and is responsible for the amidation of sidechains b, d, e and 
g of adenosylcobyrinic acid a, c diamide in organisms that operate the aerobic 
biosynthetic pathway for production of cobalamin. The synthesis of 
hydrogenobalamin by A. vinosum indicates that it has a CobQ capable of 
recognising metal free substrates. To validate A. vinosum CobQ as a suitable tool 
for the production of metal analogues of B12 the activity of this enzyme with the 
last metal free intermediate of B12 biosynthesis, HBAd was investigated.  The 
activity of recombinantly produced A. vinosum CobQ (Alvin_2223) was compared 
to that of R. capsulatus CobQ (RCAP_rcc02051) prepared in the same way with 
HBAd as the substrate. Previously Widner et al have demonstrated that CobQ 
from R. capsulatus can amidate sidechains b, d, e and g of adenosyl-rhodibyrinic 
acid a, c diamide to form adenosyl-rhodibyric acid. It has been previously 
demonstrated that R. capsulatus CobQ shows a strong specificity for substrates 
that harbour an upper adenosyl group (Widner et al 2016). A. vinosum CobQ 
should not share this specificity for adenosylated substrates and be able to 
convert HBAd to hydrogenobyrinic acid a, b, c, d, e, g hexamide (Hby). 
Purified CobQ from both A. vinosum and R. capsulatus were incubated separately 
in a solution containing a mixture of HBAd and as a result of incomplete 
purification of HBAd, HBA c monoamide along with ATP, Mg2+ and L-glutamine. 
The reaction mixture was buffered with 20 mM Tris buffer at pH 8.0 and incubated 
overnight at 30 °C (Method 2:5:4). Protein was removed by heating the reaction 
mixture to 100 °C for 5 minutes before removal of the precipitant by 
centrifugation at 36000 xg for 15 minutes. The sample was then analysed by HPLC 















Figure 3:2:3: HPLC chromatogram of a mixture of HBA mono and diamide incubated 
with either R. capsulatus CobQ (Top,) A. vinosum CobQ (middle) or no protein (bottom). 
Peak C corresponds to HBA monoamide. Peak B corresponds to HBA diamide and Peak 
A corresponds to hydrogenobyrinic acid a, b, c, d, e, g hexamide (Hby). Peak identity 
was determined by the method outlined in Method 2.6.5. 
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As shown in Figure 3:2:3 incubation of R. capsualtus CobQ with a mixture of HBA 
mono and diamide results in no change to the retention times of either compound 
when compared to an enzyme-free control. In contrast when the reaction mixture 
contains A. vinosum CobQ the peak corresponding to HBAd is reduced compared 
to the control and R. capsulatus samples. In addition to the disappearance of 
HBAd a new peak appears (Peak A) with a similar intensity to that of the peak 
corresponding to HBAd (Peak B) but with a reduced retention time (19 minutes 
peak A 22 minutes peak B). Between peaks A and B 3 minor peaks with retention 
times of 20 minutes, 20.8 minutes and 21 minutes are present in the sample. The 
reduced retention time of peak A compared to peak B indicates that at pH 2.0 this 
new species is more polar than HBAd. This change in polarity at low pH is 
consistent with the replacement of a carboxylic acid group with an amide. 
Interestingly, the peak corresponding to HBA c monoamide (Peak C) remains 
unchanged when incubated with either R. capsulatus or A. vinosum CobQs. This 
indicates that it is not recognised as a substrate by A. vinosum CobQ despite the 













3:2:1 Genomic and phylogenic analysis of CobQ 
A. vinosum is a purple sulphur bacterium belonging to the class of ɶ-
proteobacteria. These motile bacteria are highly metabolically versatile and are 
capable of photoautotrophic growth in anoxic conditions using sulphite and 
sulphide as electron donors. Chemotrophic growth is possible under microanoxic 
conditions utilising a number of organic molecules (Weissgerber et al 2011). The 
B12 requirements of A. vinosum are at present unclear. Deutsche Sammlung von 
Mikroorganismen und Zellkulturen (DSMZ) media recommendations suggest that 
B12 is added to the growth media whereas A. vinosum is described as producing 
intermediates of B12 biosynthesis (Pfennig and Trüper 1981, Toohey et al 1965). 
As with other organisms it is possible that B12 is only required and/or synthesised 
under certain growth conditions (Bobik et al 1992, Zappa et al 2010). Interestingly 
the closely related organism Allochromatium warmingii is auxotrophic for B12 
;BƌegeǇ͛s ŵaŶual of sǇsteŵatiĐ bacteriology 2nd edition 2005). 
The genome of A. vinosum has been sequenced and annotated (Weissgerber et al 
2011). Figure 3.2.4 shows a schematic view of the B12 biosynthetic genes 
identified in A. vinosum, the majority of the gene annotations are based on the 




























Figure 3:2:4: Tetrapyrrole biosynthetic genes annotated from the genome of A. vinosum. 
Genes present are coloured orange whereas genes that are not present within the genome 
are coloured grey. 
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Analysis of the A. vinousm genome shows that a vast majority of the genes 
associated with aerobic B12 biosynthesis are present. The most striking omission 
is the lack of the genes encoding both the large subunit of the cobalt chelatase 
cobN as well as one of the smaller subunits cobT, cobS is present yet all 3 
components are required to form a functional cobalt chelatase (Debussche et al 
1992). A. vinosum is also lacking the anaerobic cobaltochelatases cbiK and its 
homologue cbiX. However the genome does contain a copy of cysG, the 
ferrochelatase involved in the biosynthesis of sirohaem. It has been 
demonstrated that CysG can insert cobalt into precorrin-2 in the anaerobic B12 
pathway. However, this activity was demonstrated under artificially high 
concentrations of cobalt so may not be relevant in-vivo (Spencer et al 1993). The 
lack of a suitable cobalt chelatase is unexpected considering that the genes 
associated with aerobic B12 biosynthesis are otherwise complete barring any of 
the known cobalt reductases (cobR, btuR) and the adenosyl transferases (cobO, 
pduO). In addition to an almost complete set of aerobic B12 biosynthetic genes A. 
vinosum has a number of the genes that comprise the anaerobic B12 biosynthetic 
pathway. It lacks only the methyl transferases cbiD, cbiE and cbiT from the 
anaerobic route. Potentially the aerobic ĐouŶteƌpaƌts͛ cobF and cobL can 
substitute for these missing genes.  
The purpose of the B12 biosynthetic genes within the genome of A. vinosum is 
unclear as this organism seems to be unable to produce cobalt containing corrins 
(Toohey et al 1965). Interestingly a single B12 dependent enzyme annotated within 
the A. vinosum genome involved in bacteriochlorophyll biosynthesis implies that 
B12 is essential for this organism. The annotated gene bchE encodes a B12 
dependent radical SAM enzyme involved in the formation of ring E of 
bacteriochlorophyll under anaerobic conditions. The equivalent gene from R. 
capsulatus has been shown to be dependent upon adenosylcobalamin for activity 




Regardless of the B12 metabolism of this organism the ability of A. vinosum to 
produce Hbl would indicate that the CobQ from this organism is distinct from 
previously described CobQ sequences as it is able to recognise non-adenosylated 
compounds as substrates. In order to gain a better understanding of how the 
sequence of A. vinosum CobQ compares to that of other B12 producing organisms 
it was compared to the equivalent amino acid sequences from a range of bacteria. 
The results of this alignment are arranged in a phylogenetic tree shown in Figure 
3:2:1. A number of bacteria belonging to the order Rhodobacteraceae have 
multiple amino acid sequences within their genomes annotated as cobQ.  The 
longer CobQ sequences are typically around 520 amino acids in length whereas 
the shorter proteins that are around 480 amino acids in length. The shorter CobQ 
sequences are the most common amongst the bacteria sampled. 
Within the sampled group, bacteria belonging to the order Rhodobacteraceae are 
the only organisms to have both short and long CobQ proteins. A. vinosum is 
unique as it has a single long cobQ sequence with no annotated short cobQ 
sequence. Previously characterised CobQ sequences from P. denitrificans and R. 
capsulatus describe short sequences containing approximately 480 amino acids 
each (Crouzet et al 1991). The CobQ from both R. capsulatus and P. denitfrificans 
have strict substrate specificities accepting only substrates that harbour a β 
adenosyl group attached to a central cobalt ion (Blanche et al 19911, Widner et al 
2016). The documented production of Hbl by A. vinosum as well as the conversion 







Figure 3:2:5: Phylogenetic analysis of cobyric acid synthases from a range of 
organisms across the main bacterial phyla. The sequences of A. vinosum and R. 
capsulatus are highlighted in blue. The sequence from A. vinosum clusters with a 
number of long CobQ sequences. The short R. capsulatus sequence clusters with the 
short sequences from a number of organisms reported to synthesise B12.  
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Broadly, the aligned sequences shown in Figure 3:2:5 fall into three main groups. 
The first group within the tree is comprised of sequences belonging to a number 
of archaea and the bacteria including Dehalocoides mccartyi and Kleibsiella 
pneumonieae. The largest central portion of the tree contains sequences of many 
proteobacteria from among this group R. capsulatus, Brucella melitensis, 
Pseudomonas denitrificans, Mesorhizobium loti and Sinorhizobium meloti are 
known B12 producers operating an aerobic B12 biosynthetic pathway (Warren et 
al 2002). The final lower section of the phylogenic tree is comprised of numerous 
archaea and extremeophilic bacteria.  
Within the central branch of the phylogenetic tree two sub-groups exist, a set of 
sequences that align more closely with A. vinosum CobQ and a  second group 
comprised of sequences more similar to R. capsulatus short CobQ. The sequences 
that align with short CobQ from R. capsulatus are from bacteria that are known 
to produce B12 via the aerobic pathway. The longer CobQ sequences cluster with 
A. vinosum CobQ and are from organisms reported to produce hydrogenobalamin 
under cobalt limited conditions specifically R.capsulatus, R. rubrum, R. palustris 












To understand better the differences between long and short CobQ sequences a 
selection of CobQ sequences were chosen from the central portion of the 
phylogenic tree shown in Figure 3:2:5. Alignment of these sequences was 
achieved using a progressive pairwise alignment technique, Clustal Omega 







Figure 3:2:6: sequence alignment of CobQ sequences from bacteria known to 
produce B12 via the aerobic pathway and bacteria reported to produce 










Alignment of short and long CobQ sequences from a number of B12 producing 
organisms reveals that the main difference between short and long sequences are 
the presence of an N-terminal extension of between 29 – 20 amino acids in length 
and an insert of 12 amino acids from position 88. A third insert from positon 456 
of 5-6 amino acids is present in the long sequence from R. rubrum and A. vinosum 
that is not present in either the long or short sequence from R. capsulatus (Figure 
3:2:6). 
To date no structural data is available for any of the amidases involved in B12 
biosynthesis. However, a number of other glutamine dependent 
amidotransferases have been better characterised and the general properties of 
this class of enzyme described (Massiere et al 1998). Generally, glutamine 
dependent amidotransferases have separate domains for the deamination of 
glutamine and the attachment of the ammonia yielded by this first reaction to the 
substrate. These domains are separate and the ammonia liberated form 
aminolysis of glutamine is channelled through the protein to a synthetase 
domain. Correspondingly a catalytic cysteine residue is found within the 
glutaminase domain of all glutamine dependent amidotransferases, a single 
cysteine residue is conserved at positon 384 across all the CobQ sequences 
aligned in Figure 3:2:3. It is therefore highly likely that this cysteine residue is 
essential for the glutaminase activity of CobQ and that the C-terminal of CobQ is 
responsible for the deamination of glutamine. The N-terminal region is then most 
likely to be involved in the binding of HBAd in the case of A. vinosum CobQ. The 
insert at position 88 is therefore likely to be in the synthetase domain of CobQ 






3:2:5 Predicted structure 
Both of the amidases involved in B12 biosynthesis, CobB and CobQ have been 
characterised biochemically as part of the effort to determine the sequence of 
biosynthetic steps required for B12 synthesis (Blanche et al 19911, Debussche et al 
1992). The anaerobic equivalent of CobB (CbiA) and of CobQ (CbiP) have been 
characterised best in terms of mechanistic detail and substrate recognition 
(Fresquet et al 2004, Williams et al 2007). These studies were limited to the 
mutation of a few key residues predicted to be involved in substrate recognition 
and did not extend to any data concerning the wider architectural organisation of 
CbiP. While detailed structural data has yet to be generated for any of the 
amidases involved in B12 biosynthesis, structures are available for other glutamine 
dependent amidases. Members of this class of enzyme share many features 
particularly the separation of glutaminase and amidase activities (Massière et al 
1998). 
As described earlier glutamine dependent amidotransferses consist of two 
disparate domains, a glutamine deaminase (GAT) domain responsible for the 
deamination of glutamine to yield ammonia and glutamate. Ammonia is then 
channelled through to an ATP hydrolysing synthetase domain where it is attached 
to a phosphorylated carboxyl group of the substrate that is to be amidated 
(Massière et al 1998). CobQ is no exception to this two domain architecture 
having a C-terminal GAT domain and an N-terminal synthetase domain as 
determined by sequence alignment with other glutamine dependent 
amidotransferases (Galperin and Grishin 2000). 
Due to the wide variety of substrates that are accepted by various glutamine 
dependent amidotransferases, the synthetase domains of this class of enzyme 
show little homology aside from motifs involved in ATP binding. While the 
synthetase domains show little homology to one another, the GAT domains of 
this class of enzyme fall broadly into two groups based on sequence similarity 
(Massière et al 1998). Class I GAT domains show greater similarity to anthranilate 
synthetase and are also known as triad amidotransferases due to a conserved set 
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of three residues (cysteine, histidine and glutamic acid) within the active site of 
the GAT domain.  Class II glutamine dependent amidotransferases show greater 
homology to glutamine-phosphoribosylpyrophosphate amidotransferase 
involved in the de novo synthesis of purine bases (Muchmore et al 1998). 
For this reason the N and C termini of both R. capsulatus and A. vinousm CobQ 
were modelled separately and compared to one another. In doing so a greater 
insight into differences concerning the synthetase domains may become 
apparent. Additionally CobB and CobQ have not been classified as either class I or 
class II glutamine dependent amidotransferases.  
The N- and C-terminal portions of both A. vinosum and R. capsulatus CobQ were 
modelled separately using Phyre 2 structure prediction server (Kelley et al 2015). 
Here, the submitted sequences were compared to sequences of proteins with 
published structures, using this comparative data likely structures are modelled 
for the query sequence. 
Figure 3:2:7 shows the predicted structure of the C-terminal GAT domain of both 
A. vinosum and R. capsulatus CobQ. The super imposed predicted structures are 
shown as cartoons with residues thought to be involved in glutamine deamination 














      Figure 3:2:7 Phyre 2 predicted structure of the C terminal GAT domain of A. vinosum 
CobQ (green) and R. capsulatus CobQ (grey).  
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Figure 3:2:7 shows a superimposition of the predicted structures of the C terminal 
GAT domains of R. capsulatus and A. vinosum CobQ. Glutamine dependent 
amidotransferases are broadly divided into two groups, Class I and Class II based 
upon the similarity of the glutaminase domain to two of the earliest described 
examples (Massier et al 1998). 
The CobQs from R. capsulatus and A. vinosum show greater homology to the 
structures of class I glutamine dependent amidotransferases due to the presence 
of a likely catalytic triad comprised of histidine, glutamine and cysteine. This triad 
is a hallmark of class I amidotransferases. The predicted structure shown in Figure 
3:2:4 shows the likely arrangement of these residues in space, the predicted 
structure of R. capsulatus CobQ has these three residues arranged in such a way 
that they are spatially close enough to act as a site for glutamine deamination. 
The Predicted structure of A. vinosum CobQ shows that His 468 is angled away 
from the active site, this would suggest a non-functional protein. However, 
biochemical data (Figure 3:2:3) suggests that A. vinosum CobQ is functional and 
that the predicted orientation of His 468 in figure 3:2:7 is incorrect. A likely 



















Figure 3:2:8. Proposed catalytic mecahmism of the glutaminase domain of A. 
vinosum CobQ. Deamination of glutamine is initated by deprotonation of a catalytic 
cysteine (1-2). Resulting in the formation of a thioester and liberation of ammonia 
(3). Ammonia is channelled through the protein to a synthetase domain. The catalytic 








Figure 3:2:9 Phyre 2 predicted structure of the N- terminal synthetase domain of A. vinosum CobQ 
(green) and R. capsulatus (grey)  
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The sequence alignment shown in Figure 3:2:6 highlights a number of conserved 
residues within the N terminus of both A. vinosum (G30, G36, K37 and S8) and R. 
capsulatus (G8, G14, K15, S16) CobQ. These residues are conserved among all of 
the aligned CobQ sequences shown in Figure (3:2:6). The spatial organisation of 
these amino acids is such that they are close enough to be involved in ATP 
hydrolysis. The modelled N termini shown in Figure 3:2:9 shows that the Walker-
A motif sits within a cleft. This cleft may be the binding site for the tetrapyrollic 
substrate of CobQ as most glutamine dependent amidotransferases rely on ATP 
dependent phosphorylation of the substrate before amidation occurs.  
A. vinosum cobQ has an insert of 12 amino acids within the N-terminal region of 
the protein. This same insert is lacking in R. capsulatus CobQ. The amino acid 
sequence of this insert is proline rich as well as containing a number of negatively 
charged residues. It is therefore likely that this region is intrinsically disordered. 
As this insert is predicted to sit opposite the site of ATP hydrolysis its flexibility 
may play a role in the ability of A. vinosum CobQ to recognise and correctly 














3:2:4 X-ray crystallography 
In order to gain a greater understanding as to the substrate specificity of A. 
vinosum CobQ, attempts were made to generate the 3-dimensional structure 
through X-ray crystallography. To produce crystals of A. vinosum CobQ hanging 
drop vapour diffusion experiments were conducted. Initial screens for potential 
crystallisation conditions used the pre formulated mixtures of salts and 
precipitants from Molecular Dimensions Cambridge (Jancarik and Kim 1991). A. 
vinosum CobQ was purified initially by nickel affinity chromatography before 
further purification by size exclusion chromatography, as described in (Method 
2:5:3). The fractions corresponding to the tetrameric form of CobQ were 
concentrated to 8 mg/mL and screened by hanging drop vapour diffusion 
(Method 2:5:6). 
Initial screens used the pre-formulated structure screens 1 and 2 from Molecular 
Dimensions, however, no crystals of diffractable quality were obtained using this 
system. Additional screening was conducted using the Midas screen also from 
Molecular Dimensions (Grimm et al 2010). Small crystals of A. vinosum CobQ were 
obtained using a precipitation condition from this screen (Midas box 2, condition 
22, 28% v/v polyethylenimine 0.1 M Tris pH 8.0). 
 
 
Figure 3:2:9: SDS PAGE analysis of 
A. vinosum CobQ, initially purified 
by nickle affinity chromatography 
before further purification by size 
exlusion chromatography. The 
FPLC purification of CobQ was 
perfomed using a G200 sephadex 
column. Fractions corresponding 
to the CobQ tetramer were pooled 























Figure 3:2:10: Crystals of A. vinosum CobQ produced by hanging drop vapour 
diffusion, A. B shows the CobQ crystals mounted in a polyamide loop after freezing in 
liquid nitrogen, no cryo-protectant was added  due to the high proportion of 
polyethyenemine (28% v/v) present in the condtion. C, the diffraction pattern of CobQ 
crystals, crystals diffracted to a resolution of 6-8 Å making this data set unsuitable for 
determination of a structure. 
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While it was possible to generate small crystals of A. vinosum CobQ the quality 
could not be improved sufficiently through screening around the initial hit. Re-
screening in the presence of HBAd and glutamine did not yield crystals diffracting 























3:3:1 Discussion cloning and purification of A. vinosum CobQ 
A. vinosum cobQ was successfully cloned into a pET14b vector allowing it to be 
expressed recombinantly in E. coli with an N-terminal hexahistidine tag. The 
soluble protein produced in this way was shown to have a mass of approximately 
55 kDa when analysed by denaturing gel electrophoresis, consistent with the 
mass predicted from its amino acid sequence. Further analysis by size exclusion 
chromatography shows that in solution A. vinosum CobQ primarily exists as a 
tetramer. It has been shown that other glutamine dependent amidotransferases 
have activity that is dependent upon the oligomeric state of the protein (Lauritsen 
et al 2011). The best characterised example of this kind of regulation is exhibited 
by cytidine triphosphate synthetase where at low concentration the enzyme 
exists as a monomer but in the presence of additional enzyme and substrate CTP 
synthetase forms an active tetramer. 
A. vinosum has been described as producing Hbl when grown in media containing 
no cobalt (Koppenhagen et al 1971). The structure of Hbl proposed by 
Koppenhagen et al depicts this compound as being chemically identical to 
cobalamin but containing no central cobalt ion. The CobQ from A. vinosum is able 
to recognise HABd as a substrate and amidate it accordingly (Figure 3:2:3). 
Incubation of the last metal free intermediate of B12 biosynthesis (HBAd) with 
purified A. vinosum CobQ, ATP and glutamine. As a consequence of an incomplete 
purification of HBAd some HBA monoamide was present in the reaction mixture. 
Interestingly A. vinosum only recognises HBAd and not HBA monoamide as 
substrate. HBA monoamide remained unchanged when incubated with ATP and 
glutamine in the presence of A. vinosum CobQ. HBAd in contrast was converted 
to a new compound as reflected in a reduced retention time (Figure 3:2:3).  
Within the chromatogram shown in Figure 3:2:3 minor peaks are present with 
retention times between that of HBAd and Hby. These peaks are most likely to 
correspond to compounds with 3, 4 and 5 amide groups. The formation of these 
3, 4 and 5 amidated compounds suggests that CobQ amidates HBAd in a 
processive manner with amide groups being added to defined positions around 
the ring. Amidation at random positions around the ring would result in the 
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formation of compounds with differing retention times and therefore multiple 
peaks between HBAd and Hby (Williams et al 2007). Previous work concerning the 
homologue to CobQ from the anaerobic pathway (CbiP) proposes that CbiP 
operates using a mechanism by which the substrate molecule is released and 
rebound in a different orientation for the addition of each amide group, this 
results in each amide group being added to a defined position (Williams et al 
2007). 
Annotation of the A. vinosum genome (Figure 3:2:4) shows that this organism has 
most but not all of the genes associated with B12 biosynthesis. Notable omissions 
include any of the known cobalt chelatases (CbiK, CbiX and CobNST). Also missing 
are the genes associated with cobalt reduction (CobR) and adenosyltransfer 
(CobO). The B12 requirement of A. vinosum is also unclear as it has no annotated 
sequences for B12 dependent enzymes apart from a copy of BchE (Alv_2224). This 
enzyme is involved in the anaerobic biosynthesis of bacteriochlorophyll and is 
responsible for the formation of ring E. In vitro studies in R. capsulatus suggest 
that this process is dependent on a B12 co-factor and may represent the major use 
of B12 in this organism (Gough et al 2000). 
While A. vinosum CobQ recognises HABd and amidates it accordingly to form 
hydrogenobyric acid, the same is not true for R. capsulatus CobQ, which failed to 
alter HBAd in any way under the same conditions. Previous reports have 
demonstrated the specificity of R. capsulatus CobQ for adenosylated substrates 
(Widner et al 2016). Sequence alignment of a number of CobQ sequences from 
various organisms shows that, relative to R. capsulatus CobQ, A. vinosum CobQ 
has an N terminal extension and an insert of around 12 amino acids in the N-
terminal portion of the protein (Figure 3:2:8). Comparison of the predicted 
structures of the N-terminal synthetase domains of A. vinosum and R. capsulatus 
CobQ shows that this insert sits opposite a motif associated with ATP hydrolysis 
and a cleft in the protein that may be the site of tetrapyrrole binding. This proline 
rich insert may therefore play a role in substrate recognition.  
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In order to determine a structural reason as to why A. vinosum CobQ is able to 
amidate HBAd attempts were made to crystallise this protein. Small crystals could 
be generated but the X-ray diffraction pattern gave data to only around 7 Å 























The CobQ from A. vinosum recognises the metal free B12 biosynthetic 
intermediate HBAd as a substrate. HBAd is amidated at positons b, d, e and g by 
A. vinosum CobQ to form hydrogenobyric acid (Hby). This molecule is the metal 
free analogue of cobyric acid. The sequence alignment of A. vinosum CobQ with 
other CobQ sequences reveals a number of conserved residues. Mapping these 
residues onto the predicted structure of A. vinosum identifies a number of 

























Chapter 4: Production, isolation and 















4:1 introduction  
The final metal free intermediate of the aerobic B12 biosynthetic pathway is 
hydrogenobyrinic acid a,c diamide (HBAd). HBAd has been described previously 
in the literature as the substrate for cobalt insertion during the biosynthesis of B12 
(Debussche et al 1992). This cobalt free corrin has also been used as the starting 
material for the synthesis of the rhodium analogue of B12 (Widner et al 2016). 
HBAd is the product of CobB, a glutamine dependent amidotransferase 
responsible for the addition of amide groups to positions a and c of 
hydrogenobyrinic acid (Debussche et al 1990). After the addition of these amide 
groups the next steps in the biosynthesis of B12 involve insertion, reduction and 
adenosylation of the central cobalt ion followed by further amidation of the 
peripheral sidechains b,d,e and g.  These final 4 amide groups are added by 
cobyric acid synthase (CobQ) to generate adenosyl cobyric acid (Blanche et al 
19911).  
The first CobQ to be described in the literature was isolated from P. denitfrificans 
as part of the effort to characterise the aerobic B12 biosynthetic pathway (Blanche 
et al 19911). More recently, CobQ from R. capsulatus was employed to help in the 
chemi-bio synthesis of rhodibalamin (Widner et al 2016). Both of these CobQs 
display a preference for adenosylated substrates and will not recognise non-
adenosylated or cobalt-free substrates (Blanche et al 19911, Widner et al 2016). 
From a synthetic perspective the substrate specificity of these CobQ enzymes 
therefore limits the type of metal analogues of cobalamin that can be synthesised 
to those that can adenosylated.  
While it is theoretically possible to amidate the remaining sidechains of HBAd by 
chemical means, the lack of specificity would result in the generation of a 
compound bearing 7 amide groups. This then presents a problem as nucleotide 
loop attachment must occur at sidechain f in order to mimic B12 as closely as 
possible. It is for this reason that the regiospecific amidation of the sidechains by 
CobQ is really the only option that can be considered, as the product of this 
amidotransferase reaction retains a carboxylic acid group at positon f (Blanche et 
al 19911).  
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The previous synthesis of rhodibalamin by Widner and co-workers utilised the 
CobQ from R. capsulatus to amidate the b,d,e and g  sidechains of adenosyl 
rhodibyric acid a,c diamide before attachment of the lower nucleotide loop 
(Widner et al 2016). By alternating between enzyme catalysed and chemical 
reactions as outlined in the synthesis of rhodibalamin the efficiency of the overall 
process is reduced due to the need to separate the products after each step. It 
would therefore be a simpler process if the amidation of sidechains b,d,e and g 
could be achieved before the insertion of the chosen metal ion. 
Significantly, the isolation of CobQ from A. vinosum in Chapter 3 demonstrates 
that this enzyme will allow the direct conversion of HBAd to Hby. The ability to 
isolate large quantities of Hby would be very significant in helping generate a key 
building block for the construction of a range of different metal analogues of B12 
through the reaction scheme outlined in Figure 4:1:1. However, before that can 
be accomplished the identity of Hby as the product of the reaction between A. 
vinosum CobQ, HBAd, ATP and glutamine needs to be confirmed. In this chapter 
details of the isolation of Hby are given along with detailed characterisation of 
some of the properties of this compound.  
 
 





















Figure 4:1:1: General synthetic scheme by which analogues of B12 can be 
synthesised from HBAd. The peripheral sidechains of HBAd are labelled clockwise 
from C1 a,b,c,d,e,f and g.  
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4:2:1 Purification of HBAd 
Chapter 3 demonstrated the action of A. vinosum CobQ on the metal free B12 
biosynthetic intermediate HBAd. By using A. vinosum CobQ amide groups can be 
added to HBAd to form the metal free analogue of cobyric acid, hydrogenobyric 
acid (Hby). Crucially amidating HBAd enzymatically to form Hby should result in 
the amidation of all the carboxylic acid sidechains except for f. Differentiation of 
sidechain f is important for the specific attachment of the lower nucleotide loop 
to this position.                                  
Importantly, Hby has not previously been synthesised or isolated from natural 
sources and hence the material needs to be characterised in detail to ensure that 
its structure is correct. This, in turn requires a larger amount of the compound so 
that it can be subject to NMR analysis. To this end a pET3a plasmid containing the 
cobalamin biosynthetic genes cobA-I-G-J-M-F-K-L-H-B was transformed into E. coli 
BL21 DE3 cells. The plasmid, named pET3a-HBAd, is shown diagrammatically in 
Figure 4:2:1. The genes on this plasmid, cloned largely from the R. capsulatus 
aerobic cobalamin biosynthetic pathway, encode the enzymes that are sufficient 
for the production of HBAd when produced in E. coli (Deery et al 2012).  
Cultures (1 L) of E. coli expressing pET3a-HBAd were grown for 36 hours at 28 °C 
in 2YT media. Cells were harvested by centrifugation at 4000 x g for 20 minutes. 
The cell pellet from each 1 L culture was re-suspended in 30 mL of 10 mM 
ammonium acetate buffer (pH 7.0). Cells were lysed by heating to 90 °C for 15 
minutes. Precipitated protein was removed by centrifugation at 4500 x g and the 
supernatant was further clarified by centrifugation at 36000 x g. HBAd was 
isolated from the supernatant using weak anion exchange chromatography. 
Diethyl-amino-ethyl spehacel (DEAE resin) was equilibrated in 10 mM ammonium 
acetate buffer (pH 7.0) and the supernatant from the previous centrifugation step 
was applied to the column. Under these conditions HBAd binds to the resin and 
impurities are removed with buffers containing increasing concentrations of NaCl 
(100 mM, 150 mM). A mixture of hydrogenobyrinic acid, hydrogenobyrinic acid 
mono-amide and HBAd was washed form the column upon addition of a buffer 
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containing 300 mM NaCl. Figure 4:2:2 shows the clarified lysate bound to DEAE 





 Figure 4:2:1: Schematic representation of pet3a-AIGJFMKLHB this 
plasmid has the genes necessary to produce HBAd when expressed in 
E.coli. Cobalamin biosynthetic genes are shown in orange. The origin of 


















Figure 4:2:2: weak anion exchange chromatography (DEAE) of E.coli 
expressing pet3a-HBAd. Protein was precipitated by heat and 
removed by centrifugation. Bands A and C correspond to impurities 













Analysis of the HBAd mixture (Figure 4:2:2 band B) that was isolated from the 
DEAE column by UV-vis spectroscopy (Figure 4:2:3) gave a spectrum broadly 
similar to that of purified HBAd (Figure 4:2:5). Most notable is the strong 
absorption from 240-300 nm indicating that large amounts of protein and 
nucleotide impurities are still present in the mixture. The spectrum however, has 
features that match the previously published spectra of HBA (Deery et al 2012). 
The αβ ďaŶds at ϱϮϬ Ŷŵ aŶd ϰϵϬ Ŷŵ aƌe ǀisiďle as is the ɶ ďaŶd at ϯϮϬ Ŷŵ. The 
material purified on the DEAE column was then analysed by HPLC m/s as shown 





















DEAE 300 mM NaCl
Figure 4:2:3: UV-vis spectrum of the corrinoid material separated by DEAE 
(300mM NaCl). The spectrum was recorded from 200-800 nm in a 








Figure 4:2:4: Top HPLC chromatogram at 520 nm of HBAd purified over DEAE resin. Bottom 
left UV-vis spectrum of Peak A and corresponding mass spectrum. Bottom right UV-vis 
spectrum of peak B and corresponding mass spectrum. The data are consistent with HBAd = A 
and HBA monoamide = B. The expected mass of HBAd as calculated from the chemical formula 
(C45H62N6O12) is 879 Da. The expected mass for HBA monoamide (C45H61N5O13) is 880 Da. Peak 
identities were determined as per method 2.6.5. 
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HPLC analysis of band B (figure 4:2:2) as purified by DEAE shows a mixture of both 
HBA mono and di-amide (Figure 4:2:4). Section 3:2:3 shows that HBA mono-amide 
cannot be converted to Hby by the action of CobQ. HBA mono-amide therefore 
first needs to be converted HBAd in order to be recognised as a substrate for A. 
vinosum CobQ. To achieve this the mixture of HBA mono and di-amide was 
incubated with recombinantly produced R. capsulatus CobB in a reaction 
containing glutamine and ATP in order to enhance the level of HBAd in the 
sample. Figure 4:2:5 shows the HPLC chromatogram of HBAd with an estimated 
purity of > 95% 
Figure 4:2:5: Above HPLC chromatogram at 520 nm showing HBAd produced by the 
action of R. capsulatus CobB on a mixture of HBA mono and di amide. Below UV-vis 
spectra and corresponding mass spectrum of HBAd as separated by HPLC. Data is 
consistent with the major peak being HBAd. The expected mass of HBAd as calculated 
from the chemical formula (C45H62N6O12) is 879 Da. 
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4:2:2 In-vitro production of Hby from HBAd 
A. vinosum CobQ was expressed recombinantly with an N-terminal hexahistidine 
tag and purified by nickel affinity chromatography (method ref).  The purified 
CobQ was incubated in 10 mM Tris, buffer pH 8.0, containing 100 µM HBAd, 1 mM 
ATP, 10 mM glutamine and 2 mM Mg2+. The reaction was incubated at 28 °C for 
15 hours protected from light. The protein was denatured by heating the 
incubation mixture to 80 °C and removed by centrifugation at 36000 x g. The 












Figure 4:2:6: Reverse phase HPLC analysis of the reaction mixture used to convert 
HBAd to Hby by the action of A. vinosum CobQ. Peak A corresponds to the starting 
material HBAd, peak B is the triamide of HBA, peak C the quad amide, peak D the 
pent amide and peak E is Hby. HPLC analysis was conducted at pH 7.0 with 10mM 
ammonium acetate as the aqueous phase. Acetonitrile was used as the organic 
phase. Material was analysed using the following gradient 0-5 minutes up to 5% 
v/v acetonitrile 5-40 minutes up to 20% v/v acetonitrile. Peak Identity was 
determined as per method 2.6.5. 
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The incubation of HBAd with A. vinosum CobQ produces Hby as well as a number 
of lesser amides of HBA. HPLC analysis of this mixture was conducted at pH 7.0, 
as at this pH it is expected that the amide groups would be protonated.  From the 
chromatographic behaviour of the observed peaks (Figure 4:2:6) it is likely that 
they correspond to molecules with 3, 4 and 5 amide groups. The reduction in 
polarity of the molecules at pH 7.0 as a result of the replacement of a carboxylic 
acid with an amide resulting in progressively longer retention times for each 
species. The peak with the longest retention time (Peak E) corresponds to Hby 
with the penta-amide (Peak D), quad-amide (Peak C), tri amide (Peak B) and 
residual di-amide (Peak A) exhibiting reduced retention times consistent with the 
number of carboxylic acid moieties each molecule retains. Hby (Peak E) 





Figure 4:2:7: The reaction catalysed by A. vinosum CobQ HBAd left is converted to 
hydrogenobyric acid (Hby). Sidechains are labelled clockwise a to g. Amidated groups 
are highlighted in red. 
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4:2:3 Chromatographic separation of Hby 
Hby was also isolated from other products of the reaction between CobQ, 
glutamine and ATP by reverse phase chromatography on the bench (Method 
2:6:2). C-18 modified silica resin (particle size 25-40 ʅMͿ ǁas eƋuiliďƌated iŶ ϭϬ 
mM ammonium acetate buffer, pH 7.0. The Hby mixture was applied to the 
column and washed with increasing concentrations of methanol in the same 
ammonium acetate buffer at pH 7.0 (method). Using this reverse phase 
methodology it was possible to separate Hby from the less amidated products. 
Figure 4:2:8 shows the separation of Hby by RP-18 chromatography. Purified Hby 






Figure 4:2:8: Benchtop reverse 
phase separation of Hby from 
other amides of HBA on the 
bench. Band A corresponds to 
the diamide, band B the tri 
amide, band C is an additional 
impurity band D contains both 
the quad and penta amides 
while band E corresponds to 
Hby. Hby could be isolated with 













HPLC analysis of purified Hby shows a single peak when analysed at 520 nm. The 
retention time of this single band is identical to the retention time of band E as 
shown in Figure 4:2:9. It was possible to separate Hby from the contaminating di, 







Figure 4:2:9: HPLC chromatogram of Hby as purified by reverse phase 
chromatography. Material was analysed using the following gradient 
0-5 minutes up to 5% v/v acetonitrile 5-40 minutes up to 20% v/v 
acetonitrile the aqueous phase was 10 mM ammonium acetate pH 7.0. 
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4:2:4 In-vivo synthesis of Hby 
An alternative route towards the production of Hby was explored, here all of the 
genes required for Hby biosynthesis were expressed on a single plasmid. The 
plasmid (pET3a-Hby) contains the cobalamin biosynthetic genes cobA-I-G-J-L-M-
F-K-L-H-B in addition to A. vinosum cobQ (figure 4:2:10). 
 
 
Figure 4:2:10: Schematic representation of pET3a-AIGJFMKLHBQ this 
plasmid has the genes necessary to produce Hby when expressed in E. coli. 
Cobalamin biosynthetic genes are shown in orange, the origin of replication 
is shown in blue. 
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The pET3a-Hby plasmid was transformed into E. coli. The resulting strain 
harbouring the pET3a-Hby plasmid was cultured in 1 L of 2YT growth medium at 
28 °C for 36 hours (Method 2:3:7). Cells were harvested by centrifugation at 4000 
x g and lysed by immersion in a water bath at 90 °C for 15 minutes. Precipitated 
protein was removed by centrifugation at 4000 x g and the supernatant clarified 
further by centrifugation at 36000 x g. The supernatant was applied to a C-18 
modified silica resin that had previously equilibrated in 10 mM ammonium 
acetate buffer, pH 7.0 (Figure 4:2:11). Bound Hby was washed with increasing 
concentrations of methanol in the same ammonium acetate buffer, pH 7.0 








Figure 4:2:11: Reverse phase 
chromatography on the bench 
separating Hby from other 
contaminants derived from E. coli. 
Band A corresponds to 
contaminants derived from the E. 
coli strain used to produce Hby. 
The lower band designated B 
corresponds to Hby.  
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The HPLC analysis of band B (Figure 4:2:11) is shown in Figure 4:2:12. Band B was 
expected to contain Hby as isolated by bench top reverse phase chromatography 











In total 0.5 mg of Hby was isolated from the cell pellet of each litre of bacterial 
culture grown. The supernatant from the initial cell harvesting step was 
significantly darker in colour than the equivalent cultures when E. coli was 
expressing pET3a-HBAd. The coloured media and low amount of Hby isolated 
from the pellet suggested that perhaps Hby was able to leave the cell and could 
accumulate in the growth media.    
 
Figure 4:2:12: HPLC chromatogram of band B. The top chromatogram recorded 
at 520 nm corrpesponds to the α band of the UV vis spectrum of Hby. 
Contaminating material was identified by absorbance at 260 nm and 280 nm 
as shown in the middle (260 nm) and bottom chromatograms (280 nm). Peak 
identity was determined using the methodology outlined in method 2.6.5. 
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To determine whether Hby was indeed accumulating outside of the cell a sample 
of growth media was taken from E. coli expressing pET3a-Hby. After 36 hours of 
growth cells expressing pET3a-Hby were pelleted by centrifugation and the 
supernatant heated to 90 °C for 15 minutes to precipitate any proteins. The 
growth media was then centrifuged at 36000 x g to remove the precipitate and 







Analysis of the growth media by HPLC indicated that Hby is indeed present as 
indicated by a peak with a UV visible spectrum and mass identical to that of Hby.  
 
 
Figure 4:2:13 The top shows the HPLC chromatogram recorded at 526 nm 
of the growth media of E. coli expressing pET3a-Hby. The UV vis and m/s 
spectra correspond to the peak at 20 minutes. Both the UV-vis spectrum 
and observed mass are consistent with Hby. The expected mass of Hby 
(C45H66N10O8) is 874.51 Da. 
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4:2:4 Extraction of Hby from growth media 
 The majority of the Hby produced by cells expressing the plasmid pET3a-Hby was 
found to accumulate in the growth media. As Hby appears to be the only corrinoid 
material found in the growth media of these cells a method of extracting it could 
prove to be the most efficient way to obtain large quantities of Hby as the material 
is partly purified by excretion. Initially, reverse phase chromatography was 
employed to isolate Hby from the growth media. However, the large amount of 
contaminating material coupled with the volume of media (1 l) and slow flow rate 
of the reverse phase resin perturbed attempts to isolate Hby in this way. A more 
selective approach was required to extract Hby from such a complex mixture.  
B12 and other cobalamins are metabolically expensive molecules for prokaryotes 
to synthesise, due to the large number of biosynthetic enzymes required to 
synthesise cobalamin as well as the large amounts of ATP, SAM and glutamine 
required throughout the biosynthetic pathway. It is therefore more energy 
efficient to obtain B12 or B12 intermediates from the environment even if an 
organism is capable of de novo B12 synthesis. To this end highly specific transport 
systems have evolved in order to scavenge B12 from the environment, the low 
concentration of exogenous cobalamins has resulted in these systems showing 
remarkable affinity for B12 with Kd values in the nano molar range (Cadieux et al 
2002). One such uptake pathway is the BtuCD system found in E. coli and other 
gram negative bacteria.  
This system is formed of three components; an outer membrane transporter 
(BtuC), a globular periplasmic binding protein (BtuF) and a tonB dependent inner 
membrane transporter (BtuD) (Borths et al 2005). The crystal structure of BtuF 
(PDB 1N4A) shows the protein in complex with B12 (Karpowich et al 2003). 
Recognition of B12 seems to be due in part to numerous negatively charged 
aspartate residues lining the binding pocket and interacting with the amide 
groups at the periphery of B12. Hby shares the same pattern of amides as B12 as 
deduced from NMR experiments described in this chapter (Figure 4:2:22), Hby 
should therefore be recognised and bound by BtuF.  
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In order to employ E. coli BtuF as a means of extracting Hby from the growth 
media of cells expressing the plasmid pET3a-Hby BtuF was expressed as an N-
terminally hexahistidine-tagged protein from a pET14b plasmid (Method 2:3:6). 
Cells expressing pET14b-BtuF were lysed by sonication and the lysate clarified by 
centrifugation and loaded onto a nickel affinity column. Growth media from cells 
expressing pET14b-Hby was then loaded onto the column containing the 
immobilised BtuF. The resin was then washed with 20 mM Tris buffer, pH 8.0, 
containing 100 mM NaCl. The column appeared bright orange indicating Hby was 







Figure 2:2:14: Isolation of Hby from the media 
of cells expressing pET3a-Hby. N-terminally 
his tagged BtuF was immobilised on a nickel 
affinity chromatography column and media 
from cells expressing pET3a-Hby was added to 
the column prior to washing with 20 mM Tris 
buffer pH 8.0 containing 100 mM NaCl. The 
orange/pink colour of the column after 




In order to extract the bound Hby, BtuF was unfolded by the application of an 8 
M urea solution. BtuF could then be refolded by equilibrating the column in a 
buffer containing no urea. Upon refolding, however, the binding efficiency of the 
column was reduced resulting in less Hby being bound with each cycle of 
denaturing and refolding. For every 1 L of media processed in this way 1 L of E. 
coli expressing BtuF needed to be produced. Approximately 2 mg of Hby could be 



























4:2:4 UV-vis and mass spectroscopy analysis of Hby  
The proposed structure of Hby is presented along with the chemical formula and 
calculated mass (Figure 4:2:15). In order to confirm the structure of the isolated 
material as Hby it was subject to a range of spectroscopic techniques including 
UV-vis, mass spectroscopy and NMR. UV-vis spectra were recorded in H2O in a 
quartz cuvette with a path length of 1 cm (Figure 4:2:16). The mass spectrum of 
Hby was recorded using electrospray ionisation of purified Hby dissolved in 
methanol. The spectrum was recorded in positive mode (Figure 4:2:17).  
 
 
Figure 4:2:15: Proposed structure of hydrogenobyric acid along with the molecular 















Figure 4:2:16: UV visible spectrum of hydrogenobyric acid in H2O 220 
nm-800 nm  
Figure 4:2:17: ESI mass spectrum of hydrogenobyric acid. Sample dissolved in 
methanol prior to ionisation by electrospray. The spectrum was recorded in positive 




The UV-vis spectrum (Figure 4:2:16) matches exactly the spectrum observed with 
the red metal-free corrins as reported previously (Koppenhagen et al 1970) and 
more recently the UV-vis spectrum of hydrogenobyrinic acid (Deery et al 2012, 
Debussche et al 1992). The spectrum of Hby has two major absorption peaks with 
the ʄ ŵaǆ at ϯϯϱ Ŷŵ. This peak is desigŶated the ɶ ďaŶd. A seĐoŶd laƌge 
absorption peak at 297 nm can be seen. The smaller maxima in the visible 
wavelengths aƌe desigŶated the α ďaŶd at ϱϭϳ Ŷŵ aŶd β ďaŶd at ϰϵϯ Ŷŵ. Two 
smaller bands are present at 397 nm and 375 nm.  
An analysis of Hby by electrospray ionisation mass spectroscopy, shows a 
compound with a m/z that is in agreement with the chemical formula C45H67N10O8 
(Figure 4:2:15) with a single pseudo-molecular ion with a m/z of 875.53. The 
isotopic patterning is in agreement with the natural abundance of 13C and 15N 
















4:2:5 NMR analysis of Hby 
A number of 1D and 2D NMR experiments were conducted in order to determine 
the structure of Hby. Initially Hby was subject to NMR experiments in D2O. This 1H 
1D spectrum of Hby can be seen in Figure 4:2:18. The 1D spectrum shows signals 
for each of the non-solvent exchangeable protons in Hby. Due to the relative 
complexity of Hby 2D homo-nuclear experiments were also conducted. These 
experiments allowed for the positon of each 1H atom to be determined relative 
to one another. Correlation spectroscopy (COSY) shows protons that are within 
the same J-coupled network allowing 1H atoms on adjacent carbon atoms to one 
another to be identified. Rotating frame Overhauser spectroscopy (ROESY) 
identifies protons that are spatially close to one another. Using these spectra each 
1H atom of Hby could be assigned a chemical shift as shown in Figure 4:2:23. A 
hetero nuclear coherence spectroscopy (HSQC) experiment was conducted in 
order to determine the chemical shifts for all 13C atoms with an attached 1H atom 
(Figure 4:2:21). These experiments were only sufficient to assign the chemical 
shifts of non-solvent exchangeable 1H atoms and hence additional NMR 
experiments were required to determine the chemical shifts of the solvent 
exchangeable 1H atoms of Hby.  
The relative positions of 1H atoms exchangeable with the solvent were 
determined by conducting the same set of 1D and 2D experiments with Hby 
dissolved in 90% H2O / 10% D2O. Water suppression pulse programs were used in 
order to supress the signals from 1H atoms in water and allow the spectra of Hby 






Figure 4:2:18 : 1D 1H NMR spectra of hydrogenobyric acid in D2O. The chemical shift corresponding to HDO is 






Figure 4:2:19: 1D 1H NMR spectrum of hydrogenobyric acid in H2O exchangeable amide protons can be seen between 6.0 and 
8ppm. Two signals probably corresponding to protons attached to the pyrrole nitrogen atomsa can be seen at 13-13 ppm. Residual 
methanol from isolation of Hby is indicated with an X 
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The 1D NMR spectrum of Hby recorded in D2O shown in Figure 4:2:18 and gives 
information on the chemical environment for each of the non-solvent 
exchangeable 1H atom of Hby. The strongest signals in the spectrum correspond 
to the 1H atoms of the methyl groups decorating the macrocycle (1.15 – 2.21 
ppm). The central portion of the spectrum (2.25 - 3.55 ppm) is comprised of the 
CH2 groups of the peripheral sidechains and methine 1H atoms of the macrocycle. 
The low field signal at 5.2 ppm is characteristic of B12 NMR spectra and 
corresponds to the single 1H atom at C10 (Widner et al 2017, Summers et al 1986).  
The 1D 1H NMR spectrum of Hby recorded in 90 % H2O / 10 % D2O (Figure 4:2:17) 
gives the same signals for non-solvent exchangeable 1H atoms as the spectrum 
recorded in D2O. In addition to the peaks corresponding to non-solvent 
exchangeable 1H atoms additional peaks corresponding to 1H atoms of the 
peripheral amide groups (6.6-7.9 ppm) and pyrrole nitrogen atoms can be seen 





Figure 4:2:20: Through space 
correlations for Hby as 
determined by ROESY (dashed 
arrows) J-coupled networks 
(solid arrows) as determined by 
COSY. Chemical shifts for 1H 






Figure 4:2:21: HSQC spectrum of Hby in D2O positive signals (blue) 
correspond to carbon atoms with odd numbers of protons. Negative signals 






2D rotating overhauser spectroscopy (ROESY) and correlation overhauser 
spectroscopy (COSY) were used in order to determine the positons of each  1H 
atom relative to one another. The chemical shifts and through space correlations 
for Hby are shown in Figure 4:2:22. The positons of the amide protons were 
determined by the through space correlations to the CH2 groups of the sidechains 
(Figure 4:2:22). Unfortunately the COSY data showing J coupled protons was of 
insufficent quality for any correlations to be determiend. As such the chemical 
shifts of the amide protons were determined using the through space correlations 
generated by the ROESY pulse sequence.  
Figure 4:2:22: through space correlations for Hby in H2O. Amide protons were 
assigned by correlations to each other in order to determine the pairs and back to 
CH2 groups of the acetamide and propionamide sidechains in order to determine 
positions. The ROE signals were collected on a 600 MHz Bruker spectrometer. 




4:2:6 Biological activity of hydrogenobyric acid  
The biosynthesis of cobalamin is energetically a costly undertaking with numerous 
biosynthetic enzymes required to produce and maintain (Martens et al 2002, 
Warren et al 2002). Moreover, the biosynthesis involves many high energy 
cofactors such as SAM and the hydrolysis of large quantities ATP for the cobalt 
chelation process. It is for this reason that many organisms instead scavenge B12 
from the environment, even if they are capable of its de novo biosynthesis 
(Escalante-Semerena 2007). The production of B12 by certain bacteria and archaea 
can be investigated through the use of microbial bioassay (Taranto et al 2003, 
Roper et al 2000). Here the ability of a reporter strain to grow in the presence of 
exogenous corrin analogues is monitored. The reporter strain must be dependent 
on B12 for growth and hence must be capable of salvaging exogenously added B12 
or late intermediates of B12 biosynthesis such as cobyric acid and cobinamide. 
In this case the microbial assay used to investigate Hby was based on a strain of 
Salmonella enterica. The strain is deficient in the B12 independent methionine 
synthase (MetE) and is reliant on an alternative B12 dependent methionine 
synthase (MetH) when grown in the absence of methionine on minimal media. A 
second gene deletion in cysG prevents the S. enterica from synthesising B12. The 
earliest exogenous intermediate that can be taken up and used to fulfil the B12 
requirement of S. enterica is cobyric acid. The result of these deletions produces 
a strain of S. enterica that requires either the addition of exogenous B12, an 
intermediate between cobyric acid and B12 or methionine to sustain growth on 
minimal media (Raux et al 1996).  
Application of a solution of Hby to S. enterica embedded in agar (Method 3:3:8) 
does not stimulate the growth of this organism (Figure 4:2:23). Additionally when 
a solution of Hby is dropped adjacent to a solution of B12 the stimulatory effect of 
B12 is no longer present at the interface of the solutions (Figure 4:2:23). This zone 
of inhibition is concentration dependent with higher concentrations of Hby 












To investigate this inhibitory effect further the same strain of S. enterica was 
grown in liquid culture. To stimulate the growth of S. enterica B12 was added at a 
concentration of either 10 nm (Figure 4:2:24) or 1 nm (Figure 4:2:25). In addition 
to this Hby was added at various concentrations and the cells allowed to grow at 
37 °C (Method 2:3:9).   
 
 
Figure 4:2:23: Salmonella bioassay plate. Vitamin B12 (1 μmole in 
5μL H2O) was dropped onto M9 minimal media agar containing 
Salmonella. 1 μmole Hby in 5μL H2O and 10 μmoles was dropped 
next to vitamin B12 the point at which the drops were placed is 





The degree of inhibition exhibited by Hby is concentration dependent with higher 
concentrations of Hby reducing the overall growth of S. enterica to a greater 
extent than lower concentrations (Figure 4:2:24). This is also true when B12 is 
more limiting (Figure 4:2:25), however, the highest concentration of Hby coupled 
with the lowest concentration of B12 Hby appears to exert a bactericidal effect 
after 13 hours.   
Figure 4:2:24:  growth curve of Salmonella enterica ΔMetE ΔCbiB grown in M9 minimal 
media the presence of vitamin B12 at a concentration of 10 nM. Hby was added at a 
concentration of 10nM, 40 nM and 80 nM. The OD 600 was recorded every 10 minutes 
for 24 hours. Salmonella was grown in 1ml M9 in a 24 well plate at 37⁰C with shaking. 
































4:3:1 Discussion: Production isolation and characterisation of Hby 
The structure of Hby was confirmed by NMR spectroscopy, using a combination 
of experiments conducted in both D2O and H2O. NMR experiments conducted in 
D2O gave information about the chemical environment of each of the 1H atoms 
that are unable to exchange with the solvent. The positons of each 1H atom 
relative to one another was determined by COSY and ROSY experiments. Initial 
2D homonuclear experiments conducted in D2O gave the expected positions for 
each of the non-solvent exchangeable 1H atoms. Experiments conducted in D2O 
were unable to provide any information about the exchangeable amide 1H atoms.  
In order to determine the positons of each of the amide 1H atoms relative to other 
1H atoms in Hby a new set of NMR experiments were conducted in H2O. This 
allowed for the relative positions of the exchangeable amide 1H atoms to be 
determined and confirms that Hby shares the same pattern of amide groups as 
B12. Interestingly signals were also observed that corresponded to the 1H atoms 
attached to the pyrrole nitrogen atoms at the centre of the Hby macrocycle. Of 
these two atoms it was only possible to assign the position of one of them using 
the available data from a ROESY experiment (Figure 4:2:22).  
The mass of Hby is also consistent with the mass of the predicted structure for 
Hby (Figure 4:2:15). Finally the UV-vis spectrum of Hby is identical to the 
previously reported spectrum of HBA (Deery et al 2012) and hydrogenobalamin 
(Toohey 1965) this indicates that the chromophore of each molecule is identical. 
The combination of NMR, UV-visible and mass spectra are sufficient to confirm 
that the proposed structure of Hby is correct.  
The structure of Hby shows that it is the metal free analogue of the B12 
biosynthetic intermediate cobyric acid. Many B12 requiring organisms are capable 
of importing exogenous B12 or intermediates of B12 biosynthesis. The earliest 
intermediate imported in this way is cobyric acid. These molecules are then 
converted to a functional form of B12 and used to fulfil the B12 requirement of the 
organism. Supplementing S. enterica with Hby results in no stimulatory effect in 
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the same way as supplementation with B12 and indicates that Hby is not converted 
to B12 by S. enterica under the conditions assayed. 
Extraction of Hby from the growth medium of cells expressing pET3a-Hby using 
the E. coli periplasmic B12 binding protein BtuF demonstrated that Hby is 
recognised and bound by at least this component of the B12 import machinery of 
E. coli. Recognition of Hby by BtuF is due to multiple aspartate and glutamate 
residues lining the binding pocket of BtuF (PDB: 1N4A) and these negatively 
charged residues interact with the amide sidechains of B12 in the crystal structure 
of E. coli BtuF (Karpowich et al 2003). NMR analysis of Hby shows that it shares 
the same pattern of amides as B12 (Figure 4:2:22). The antagonistic effect of Hby 
on the growth of S. enterica when combined with B12 in solid culture (Figure 
4:2:23) and liquid culture (Figure 4:2:24) is possibly due to competition between 
Hby and B12 for uptake via the BtuBCDF transport system. 
The majority of the Hby produced by cells expressing pET3a-Hby accumulated in 
the growth media. This is in contrast to HBAd, which remains in the cells 
expressing the plasmid pET3a-HBAd. Structurally HBAd and Hby are highly similar 
and the only difference between the two molecules is the pattern of amides 
attached to the peripheral sidechains. As Hby is the only corrinoid that can be 
detected in the growth media of cells expressing pET3a-Hby this implies that Hby 
is specifically transported out of the cell and into the growth media. To date no 
B12 export system has been identified. It is, however, possible that Hby is exported 
via the BtuCD B12 import system. The role of this transport complex in Hby 
excretion could be investigated by knocking out either the BtuC or D component 
of this system.  
Paradoxically the excretion of Hby into the growth media complicated the 
extraction and purification of this molecule. Large amounts of contaminating 
excreta present in the growing medium coupled with the large volumes (1 l) 
precluded the use of reverse phase chromatography for the isolation of Hby. The 
charge of the amide sidechains prevented the use of faster flowing anion 
exchange chromatography used as part of the purification of HBAd. It is possible 
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that cation exchange chromatography would be suitable for the extraction of Hby 
from this mixture. As a result of difficulties encountered isolating Hby from the 
growth media of cells expressing pET3a-Hby the most efficient way to produce 
sufficient Hby to allow for its spectroscopic characterisation and the synthesis of 
metal analogues was to begin from HBAd.  
As HBAd remains in the cell, the lower volumes involved greatly aided the 
extraction process as 2.5 mg of HBAd was concentrated in approximately 30 mL 
of cell lysate as opposed to 2 mg of Hby in 1 l of growth media. Even with the 
additional step of using A. vinosum CobQ to convert HBAd to Hby. In vitro 
production of Hby from HBAd proved the most efficient way to produce the 
required amounts of Hby. In order to have sufficient material for the 
spectroscopic characterisation of Hby and the synthesis of a zinc analogue of 
cobalamin around 100 mg of Hby was produced in total. 
HPLC analysis of the reaction mixture containing HBAd and A. vinosum CobQ gives 
single sharp peaks corresponding to the di, tri, tetra, penta and hexa-amide of 
HBA. This chromatographic behaviour indicates that the position of each amide 
group is fixed. Previous work has shown that CbiP, the CobQ homologue from the 
anaerobic pathway, amidates its substrate adenosyl cobyrinic acid a,c diamide in 
a sequential fashion (Williams et al 2007). The similarities between CobQ and CbiP 
in terms of sequence and function point towards CobQ adopting a similar reaction 
mechanism in which HBAd is bound amidated and released from the active site 










Of the two routes explored for the synthesis of Hby the most efficient method of 
producing Hby was to synthesise this molecule in vitro from HBAd using 
recombinantly produced A. vinosum CobQ to catalyse the amidation reaction. 
Efforts to produce Hby in vivo were frustrated by the excretion of this molecule 
into the growth media. 
Spectroscopic analysis of Hby confirmed the structure of this molecule, showing 
it to be the metal free analogue of cobyric acid. 
Hby was shown to be unable to stimulate the growth of a strain of S. enterica 
dependent on exogenous B12 for growth. Hby did, however, bind to the 
periplasmic component of the BtuCDF uptake system. Binding of BtuF to Hby may 
explain the inhibitory effect Hby has on the growth of S. enterica as Hby can 






















Chapter 5: Synthesis and characterisation of 















5:1:1 Introduction zinc analogues of cobyric acid and cobalamin 
The zinc analogue of B12, zincobalamin (Zbl), has been synthesised previously from 
hydrogenobalamin (Hbl) (Koppenhagen et al 1971). The small amounts of 
compound synthesised meant that this molecule was analysed only by UV-vis 
spectroscopy and the structure was implied from the predicted structure of the 
starting material (Hbl). Further work would investigate the binding of Zbl to parts 
of the cobalamin uptake pathway in humans (Elshans et al 2008). Zbl specifically 
was shown to bind to human transcobalamin II, haptocorrin and intrinsic factor. 
These three proteins represent the main components of the cobalamin uptake 
pathway in humans. 
The aim of the research described in this chapter was to synthesise zincobalamin 
from the more easily obtainable hydrogenobyric acid (Hby). Two synthetic steps 
need to be completed, including the insertion of a zinc ion into the metal free 
macrocycle and secondly the attachment of the lower nucleotide loop to 
sidechain f. Potentially the order of these steps is interchangeable as sidechain f 
is chemically distinct from the other 6 sidechains of Hby making lower loop 
attachment specific for this position. Likewise, metal insertion can proceed either 
pre- or post - loop attachment as the status of the sidechains should have no 
bearing on the metalation reaction of the ring. However, previous work has 
demonstrated that, thermodynamically, the most favourable site of attachment 
for the lower nucleotide loop is sidechain f if a metal ion is present in the centre 
of the macrocycle (Eschenmoser 1988). In order to take advantage of this 
intramolecular catalysis to enhance the covalent linkage of the complete lower 
nucleotide loop zinc was first inserted into the macrocycle of Hby to form 
zincobyric acid (Zby). 
The lower nucleotide loop of cobalamin is formed of two parts. The first of these 
is the amino propanol linker that is attached directly to sidechain f forming an 
amide bond. The second is the phosphodiester bonded α-ribazole nucleotide; this 
group is attached to the aminopropanol group by the ribose sugar. There is some 
variation between the nucleotide selected by different organisms. In the case of 
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vitamin B12 this nucleotide is dimethylbenzimidazole (DMB) (Brink and Folkers 
1949).  
Carbodiimide coupling has been used previously to attach the lower nucleotide 
loop of B12 to the rhodium analogue of adenosylcobyric acid in order to produce 
rhodibalamin, the rhodium analogue of B12 (Widner et al 2016).  Herein the same 
approach is applied to determine if the zinc analogue of cobalamin can be 






















5:2:1 Synthesis of zincobyric acid 
The synthesis of zincobalamin has been described previously (Koppenhagen et al 
1971). In this work Hbl was boiled with an excess of zinc acetate in aqueous 
solution in order to produce zincobalamin. As Hbl is not available as a starting 
material for the synthesis of Zbl the zinc analogue of cobyric acid, Zby was 
produced en-route to the final product Zbl. The predicted structure of this 






Figure 5:2:1: proposed structure of Zincobyric acid (Zby). The 
chemical formula for the structure is presented along with the exact 
and formula masses for this compound 
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To produce sufficient Zby for characterisation by NMR and to screen for activity 
as a potential anti-vitamin a large amount of this compound needed to be 
produced. Synthesis of Zby followed a very similar reaction scheme to the one 
outlined by Koppenhagen and co-workers when producing Zbl.  
Hby (6.93 mg) along with 20 molar equivalents of zinc acetate (34 mg) and 4 
equivalents of sodium acetate (2.6 mg) was dissolved in 10 ml of H2O degassed 
under argon. The reaction mixture was incubated at 50 °C under an argon 
atmosphere for 90 minutes. The reaction scheme is shown in Figure 5:2:2. The 
reaction was stopped by binding of the reaction mixture to a C-18 modified silica 
resin and washing away residual salts with H2O before the material was eluted 










Figure 5:2:2: reactions scheme showing the synthesis of zincobyric acid 
(Zby) from Hydrogenobyric acid (Hby). 
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5:2:2 UV-vis mass spectroscopy zincobyric acid  
Zincobyric acid synthesised and purified as described in Section 5:2:1 was 






Figure 5:2:2: UV-vis spectrum of zincobyric acid recorded in H2O in a quartz 
cuvette with a 1 cm path length. The spectrum was recorded between 220 nm 
and 700 nm. 
Figure 5:2:3: Mass spectrum of purified Zby dissolved in methanol 
and ionised by electrospray. Spectra were recorded in positive 
mode. The expected mass for Zby (C45H64N10O8Zn) is 936.42. 
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The UV visible absorption spectrum of Zby gives the same general features as the 
spectrum of Hby and the previously reported spectrum of HBA (Deery et al 2013). 
The same features are present across all three spectra although the presence of 
a zinc ion at the centre of the macrocycle shifts the maximum absorbance 
ǁaǀeleŶgth of the α, β aŶd ɶ ďaŶds ǁheŶ Đoŵpaƌed to the speĐtƌuŵ of HďǇ.  
band Zby Wavelength (nm) Hby Wavelength (nm) 
α 525 520 
β 493 496 
ɶ 335 326 
 
 The largest change in comparing the spectrum of Zby to that of Hby is the absence 
of aŶǇ aďsoƌďaŶĐe ŵaǆiŵa ďetǁeeŶ the β aŶd ɶ ďaŶds of the )ďǇ speĐtƌuŵ. The 
absorbance spectrum of Hby shows two small maxima at 396 nm and 378 nm 
(Figure 4:2:16).  
 
Analysis of Zby by mass spectroscopy gives a pseudomolecular ion with a m/z ratio 
of 937.47. The unusual isotopic pattern of the various ions is due to the isotopic 
distribution of zinc isotopes with 64Zn being the most abundant isotope (50%) 















5:2:3 NMR analysis of Zby 
Zby was analysed by NMR spectrosocpy. The 1D spectrum of of Zby recorded in 
D2O is shown in Figure 5:2:4. To detemine the positions of 1H atoms relative to 
one another nuclear overhauser spectroscopy was used, specifically ROESY and 
COSY experiments (Figure 5:2:5). A ROESY experiment was used in order to 
determine which 1H atoms are spatially close to one another. A COSY spectrum 
was recoreded in order to determine which 1H atoms are adjacent to one another. 
A heteronuclear HSQC spectrum was recorded in order to determine the 13C 















Figure 5:2:4: 1D 1H spectrum of zincobyric acid in D2O recorded on a Varian 500 MHz 









The 1D NMR spectrum of Zby shows the expected features for this molecule. 
Signals for each of the methyl groups can be seen between 1.17 ppm to 2.22 ppm. 
The CH2 groups give signals between 1.84 ppm to 2.68 ppm. The single `1H atom 
at C10 gives a distinictive low field signal at 5.51 ppm. The postions of the 1H 
atoms relative to one another were determined by a ROSY pulse sequence. 1H 
atoms attached to adjacent carbon atoms were correlated via a COSY pulse 
sequence.  
Figure 5:2:5: Through space correlations (dashed arrows) as determined by 
ROESY and J-coupled systems as determined by COSY (solid arrows). Chemical 





 Figure 5:2:6 HSQC spectrum of Zby recorded in D2O  
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5:2:4 Biological activity of Zincobyric acid 
The biological activity of zincobyric acid was investigated using a Salmonella 
bioassay system (Method 3:3:8). A strain of S. enterica (AR2680; metE, cysG) 
dependent on exogenous cobalamins for growth was embedded in agar. Upon 
the addition of B12, cobinamide or cobyric acid the growth of S. enterica is 
stimulated the size of the area of growth being roughly proportional to the 
amount of B12 added. Structurally Zby resembles the B12 biosynthetic 
intermediate cobyric acid and as such should be recognised and taken up by S. 
enterica. The central zinc ion of Zby should be unable to fulfil the same role as the 





Figure 5:2:7: Bioassay plate with Zby and Cbl, 5 μL of Cbl at a concentration of 1 
μM was dropped adjacent to 5 μL drops of Zby at a concentration of 1, 2 and 8 




Addition of a solution containing Zby directly to agar containing S. enterica results 
in no stimulation of S. enterica growth (Figure 5:2:7). Additionally the experiment 
demonstrates that when Zby is dropped adjacent to a drop of Cbl, Zby exerts an 
inhibitory effect on the growth of S. enterica. Zby prevents the Cbl stimulated 
growth of the S. enterica at the interface of the two drops. This interface will be 
where the concentration of Zby is highest relative to the concentration of Cbl. 
Higher concentrations of Zby exaggerate this inhibition as seen by the larger zone 









Figure5:2:8: Bioassay plate 
showing the effect of Zby on 
Salmonella AR2680 cysG, 
metE in competition with Cbl. 
5 μL of Cbl at a concentration 
of 1μM was dropped onto a 
bioassay plate. 5 μL of Zby at 
a concentration of 1, 2, or 8 
μM was dropped at the same 





The inhibitory effect of Zby can also be seen on the bioassay plate when Zby is 
mixed directly with Cbl at various ratios (Figure 5:2:8). Although addition of a 
mixture of both Zby and Cbl still stimulates the growth of S. enterica the density 
of the growth circles is lower than that of the Cbl only control. Interestingly the 
diameter of the growth circles is roughly the same as that of the Cbl only control. 
The reduction in density of S. enterica growth is proportional to the concentration 
of Zby applied to the plate with higher concentrations exhibiting lower density 




















5:2:5 Chemical stability of Zby 
Zby is susceptible to degradation in the presence of oxygen and light, this was 
observed when handling solutions of Zby. Exposure of red fluorescent solutions 
of Zby become yellow within a few hours when left in direct light. Protecting Zby 
from light with aluminium foil extends the time it takes for solutions of Zby to 
become yellow. The same is true for solutions of Hby when exposed to direct light 
for prolonged periods of time, although the formation of yellow compounds in 
this case is slower. 
The yellow products of Hbl and Zbl have been described previously in the 
literature (Toohey et al 1965; Koppenhagen et al 1970). It was found that Zbl 
degrades to form a yellow compound when exposed to light.  No structures for 
the yellow compounds of Hbl or Zbl have been solved by either x-ray 
crystallography or by NMR spectroscopy. Structural data does exist for the yellow 
products of cobalt containing corrins as well as for HBAd (Dresow et al 1980; 
Grüning et al 1985). The data presented by Dresow et al suggest a structure for 
the yellow product of HBAd along with a UV-vis spectrum. The spectrum of the 
yellow product is identical to the observed UV-vis spectrum of yellow solutions of 
Zby (Figure 5:2:9). Changes to the chromophore as observed by UV-vis 
spectroscopy reflect changes in the arrangement of double bonds around the 
macrocycle of HBAd and Zby. The identical nature of the spectrum of the yellow 
product of Zby and the yellow product of HBAd are consistent with the formation 






The UV-vis spectrum of the Zby derived yellow compound shows a broad maxima 
at 440 nm and a sharper maxima at 290 nm. The spectrum of the yellow product 
of Zby is very similar to that of the yellow product of zincobamide as reported by 












Figure 5:2:9: Proposed structure of the yellow product of zincobyric acid (left) 
alongside the UV-vis spectra of the compound in H2O. 
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5:2:6 Co-ordination of Zby 
The next step towards the synthesis of zincobalamin after zinc insertion to form 
Zby, is the attachment of the lower nucleotide loop. Previous work concerning the 
total synthesis of B12 gave some indication that the presence of a metal ion at the 
centre of the corrin ring allows the nucleotide loop to pre-coordinate in the 
correct orientation such that sidechain f is the most thermodynamically 
favourable site for attachment of the loop (Eschenmoser 1988). This is shown 












The co-ordination of Zby by a nitrogen containing base was investigated 
spectrophotometrically. N-methyl imidazole was mixed with Zby and a UV-visible 
absorption spectrum was recorded. N-methyl imidazole was used as a proxy for 
the dimethylbenzimidazole moiety of the lower nucleotide loop due to its 
increased solubility in water. The UV-vis spectra recorded on addition of various 
concentrations of N-methyl imidazole are shown in Figure 5:2:9.  
)Ŷ )Ŷ 
Figure 5:2:10: Schematic representation of the 
intramolecular positioning of the lower nucleotide loop 
prior to formation of the amide bond between Zby and the 













The change in spectrum upon addition of N-methyl imidazole indicates a change 
in the groups acting as ligands for the zinc ion of Zby. The ɶ ďaŶd at ϯϯϱ Ŷŵ is 
supressed somewhat at the highest concentration of N-methylimidizole while the 
α,β ďaŶds shift from α 517 nm to 521 nm and β 492 nm to 496 nm. These changes 
are concentration dependent with lower concentrations of N-methyl imidazole 



























Figure 5:2:11: UV-vis spectra of Zby in 10 mM ammonium acetate pH 7.0  with 
increasing concentrations of N-methyl imidazole spectra were recorded in a quartz 


















The final step in the synthesis of zincobalamin is the attachment of the lower 
nucleotide loop to the f sidechain of Zby. Peptide coupling chemistry was used in 
order to form an amide bond between the amine group of the free nucleotide 
loop and the propionic acid function of sidechain f of Zby. N-(3-
Dimethylaminopropyl)-N͛-ethylcarbodiimide hydrochloride (EDC*HCl) was used 
in order to activate the propionic acid of sidechain f making it more reactive 
towards the amine group of the free nucleotide loop it is converted to a more 
reactive O-acylisourea. This highly reactive group was converted to an ester with 
hydroxybenzotriazole (HOBT) as the reduced reactivity prevents the formation of 





Figure 5:2:12: Reaction scheme for the synthesis of zincobalamin from 
Zby and free lower nucleotide loop. Carbodiimide coupling was used to 
attach the lower nucleotide loop to sidechain f. 
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The free nucleotide loop of B12 used in this synthesis was kindly provided by 
Professor B. Kräutler at the University of Innsbruck as a free amine. However, this 
molecule could feasibly be generated by selective aminolysis of cobalamin by 
either enzyme or chemical means (Woodson et al 2006; Zou et al 1995). 
Alternatively, well documented synthetic schemes specific to the synthesis of the 
α eŶaŶtioŵeƌs of α ƌiďazole ĐoŶtaiŶiŶg ŶuĐleotides Đould ďe used iŶ oƌdeƌ to 
generate the dimethylbenzimidazole nucleotide as well as analogues on the gram 
scale (Chandra et al 2005, 2006, 2008). 
 Zincobyric acid (4.71 mg) was mixed with 2.21 mg (1.1 equivalents) of lower 
nucleotide loop along with 2.3 mg (2 equivalents) of hydroxybenzotriazol. The 
reactants were dissolved in 2.5 ml of H2O and stirred at room temperature under 
an argon atmosphere. 9.3 mg (9.4 equivalents) of 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide hydrochloride (EDC*HCl) was dissolved in 
500 ʅL H2O. The two solutions were mixed under an argon atmosphere and 
allowed to react at room temperature for 4 hours. The reaction was stopped by 
binding the material to RP-18 resin equilibrated in 10 mM ammonium acetate. 
The resin was washed with 10% acetonitrile followed by 15% acetonitrile in 10 
mM ammonium acetate pH7. Zincobalamin was eluted in 30% acetonitrile. 
Acetonitrile was removed by rotary evaporation. Zincobalamin (6.62 mg) was 
produced in this way giving a yield of 96%. The proposed structure of 



















Figure 5:2:13:  Proposed structure of zincobalamin along 
with the chemical formula and molecular mass. 
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5:2:7 UV-vis mass spec analysis of Zbl 
Zincobalamin was analysed by UV-vis spectroscopy (Figure 5:2:14) and mass 
spectroscopy (Figure 5:2:15).  
The UV-vis spectrum of zincobalamin (Figure 5:2:14) retains many of the features 
of the speĐtƌa of )ďǇ aŶd HďǇ ǁith a laƌge ɶ ďaŶd at ϯϰϵ Ŷŵ aŶd α, β ďaŶds at ϱϯϬ 
nm and 502 nm. A comparison of the UV-vis spectrum of Zby (Figure 5:2:2) to Zbl 
(Figure 5:2:12) ƌeǀeals that the ɶ ďaŶd of )ďl ϯϰϵ Ŷŵ has uŶdeƌgoŶe a 
ďathoĐhƌoŵiĐ shift ǁheŶ Đoŵpaƌed to the ɶ ďaŶd of )ďǇ ϯϯϱ Ŷŵ. The α (502 nm) 
aŶd β (530 nm) bands of Zbl have undergone a similar shift when compared to the 




Figure 5:2:14: UV-vis spectrum of zincoabalmin recorded in H2O and measured 
in a quartz cuvette. 
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The mass spectrum gives a pseudomolecular ion with a m/z of 1334.6 in keeping 
with predicted mass of Zbl. The isotopic pattern of zinc can still be seen in the 
spectrum indicating it is still present. Two higher mass species can also be seen, 









Figure 5:2:15: Mass spectrum of Zbl dissolved in methanol and ionised by 
electrospray. The pseudomolecular ion can be seen at 1334.6 m/z along with 
the sodium adduct at 1356.67 m/z and the potassium adduct at 1366.53 m/z. 
The expected mass for Zbl (C62H88N13O14PZn) is 1333.56 Da. 
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5:2:8 NMR analysis of Zbl  
Zbl was analysed by NMR spectroscopy and the 1D spectrum of Zby in D2O is 
shown in Figure 5:2:16. A ROESY experiment was used in order to identify 1H 
atoms that are spatially close to one another. 1H atoms on adjacent carbon atoms 
were identified by COSY. The couplings from these two experiments are depicted 














The 1D 1H NMR spectrum of Zbl shown in Figure 5:2:16 shares many of the 
chemical features of the Zby (Figure 5:2:4). Signals corresponding to the methyl 
groups of Zbl are in the region between 0.5 to 2.9 ppm. Compared to the spectrum 
of Zby the Zbl spectrum contains signals corresponding to the methyl group that 
forms part of the amino-propanol linker comprising the lower nucleotide loop. 
The low field portion of the spectrum 5.5 to 7.8 ppm contains signals 
corresponding to the methyl groups of dimetylbenzimidazole.   
Through space correlations for the 1H atoms of Zbl were generated using a ROESY 
pulse sequence. Long range coupling between DMB attached 1H atoms and 1H 
atoms of methyl groups attached to the corrin ring suggest that at least under 
neutral aqueous conditions the lower nucleotide loop of Zbl adopts a base on 
conformation. 
 
Figure 5:2:17: Through space 
correlations between 1H atoms 
as determined by ROESY 
(dashed arrows). J couplings 
between adjacent 1H atoms as 
determined by COSY (solid 
arrows). Chemical shifts for 1H 






Figure 5:2:18: 2D 1H 13C HSQC allowing the chemical shifts for 
13C atoms attached to 1H atoms to be determined.  
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5:2:9 biological activity of Zbl 
The activity of Zbl as a B12 antagonist was investigated through the use of the plate 
bioassay used to investigate the activity of Hby and Zby. Here a reporter strain of 
S. enterica AR2680 cysG, metE was embedded in agar as described in Method 
2:3:8. Growth of S. enterica in this bioassay is dependent on the cofactor activity 
of methyl cobalamin with the enzyme methionine synthase (MetH). This enzyme 
requires the methyl transferase activity of methyl cobalamin to generate 
methionine from homocysteine, as no other sources of methionine are available 
to S. enterica therefore the growth of S. enterica is dependent upon exogenous 
B12 or methionine (Raux et al 1996). The activity of B12 in methionine synthase is 
due to the carbon cobalt bond between the central cobalt ion of B12 and the 
attached methyl group (Banerjee et al 1990). As zinc should be unable to form the 










Additon of Zbl alone shows that this molecule is unable to promote the growth of 
S. enterica dependent on exogenous B12. Therefore, Zbl is unable to fulfil the same 
role as its cobalt containing counterpart in acting as a cofactor for methionine 
synthase. As with Zby and Hby, Zbl perturbs the B12 stimulated growth of S. 
enterica. The inhibiton is again at the interface of the B12 and Zbl drops and is 
concentration dependent with higher concentrations of Zbl exhibiting a greater 
inhibitory effect.   
 
Figure 5:2:19: Bioassay investigating 
the effect of Zbl on B12 dependent S. 
enterica. Here 5 μL of a 1 μM solution 
of B12 was dropped adjacent to 5 μL of 
a Zbl solution at 1, 5 and 10 μM. The 
position of each drop is marked by a 







Addition of Zbl in conjunction to a fixed amount of B12 results in circles of S. 
enterica growth with a larger diameter than that of the Cbl only control. Despite 
the larger diameter of  growth circle the density of  S. enterica is reduced 
comapred to the control spot. Previous work concerning rhodibalamin showed 
that the rhodium analogue of adenosyl-cobalamin exhibits a similar effect on the 
growth of S. enterica under similar conditions (Widner et al 2016).  
 
Figure 5:2:20: 5 μL of B12 at a concentration of 1 μM was dropped onto a bioassay 
plate. Adjacent to this 5 μL of Zbl was dropped at a concentration of 1, 5 or 10 μM.    
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5:2:10 synthesis of hydrogenobalamin 
Previous work has proposed that sidechain f is thermodynamically the preferred 
positon for nucleotide loop attachment if the loop can coordinate a metal ion at 
the centre of the corrin ring prior to bond formation at sidechain f (Eschenmoser 
1988). The role of the metal ion at the centre of Zby in improving the efficiency of 
the nucleotide loop coupling reaction was investigated by conducting the 
analogous reaction in a metal free system. In order to test this hypothesis the 
lower nucleotide loop was joined to sidechain f by carbodiimide coupling to form 





Figure 5:2:21: Proposed structure of hydrogenobalamin 
along with chemical formula and mass. 
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Hydrogenobyrinic acid (0.5 mg) was mixed with 0.26 mg (1.1 equivalents) of lower 
nucleotide loop along with 0.15 mg (2 equivalents) of hydroxybenzotriazol. The 
reactants were dissolved in 1 ml of H2O and stirred at room temperature under 
an argon atmosphere. To this solution 1.03 mg (9.4 equivalents) of 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide hydrochloride (EDC*HCl), dissolved in 500 ʅL 
H2O. The two solutions were mixed under an argon atmosphere and allowed to 
react at room temperature. After 4 hours a sample of the reaction mixture was 








Figure 5:2:22: Comparison of the coupling reactions between Hby and 
the lower nucleotide loop after 4 hours (top) and coupling the lower 
nucleotide loop to Zby bottom.  
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HPLC analysis of the lower loop coupling reaction between Hby and the lower 
nucleotide loop shows that after 4 hours only 15 % of the material in the reaction 
mixture is hydrogenobalamin as determined by its retention time. A majority of 
the Hby present (51 %) remains unreacted. A third peak at 34.4 minutes probably 
corresponds to an intermediate of the coupling reaction. In contrast to this the 
analogous coupling reaction between Zby and the lower nucleotide loop is 
completed by this time as HPLC analysis of the reaction mixture shows a single 




















5:2:11 UV-vis and mass spectral analysis of Hbl 
Hbl was isolated from the lower loop coupling reaction mixture by reverse phase 
chromatography. Purified Hbl was analysed by UV vis spectroscopy (Figure 5:2:23) 









Figure 5:2:23: UV-vis spectrum of Hbl dissolved in H2O. The spectrum 









The UV-visible absorbance spectrum of Hbl shows strong similarity to the 
equivalent spectrum of Hby (Figure 4:2:16). The ɶ ďaŶd of Hďl is at ϯϮϵ Ŷŵ 
ǁheƌeas it is shifted slightlǇ iŶ HďǇ ďeiŶg pƌeseŶt at ϯϮϱ Ŷŵ. The α aŶd β ďaŶds 
of Hbl have maxima at 525 nm and 496 nm respectively. Again these bands are 
shifted ƌelatiǀe to the speĐtƌuŵ of HďǇ ǁheƌe the α aŶd β ďaŶds aƌe pƌeseŶt at 
517 nm and 493 nm (Figure 4:2:16).  
Mass spectral analysis of Hbl gives a pseudo-molecular ion at 1272.73. This mass 
is in keeping with the mass of the formula for Hbl proposed in Figure 5:2:21. Two 
higher mass species are also present corresponding to the sodium and potassium 
adducts of Hbl. 
 
 
Figure 5:2:24: Mass spectrum of Hbl dissolved in methanol the 
pseudomolecular ion is present at 1272.73 m/z the sodium 




Zbl was synthesised from Hby via the zinc containing intermediate Zby. Inserting 
zinc into the macrocycle of Hby was successful with yields of Zby approaching 95% 
after purification. Characterisation of Zby by UV-vis spectroscopy revealed that 
insertion of zinc into the macrocycle of Hby produces a compound with different 
spectral properties compared to the starting material. Changes in the UV-vis 
spectra of both Zby and Zbl relative to Hby and Hbl show that the presence of a 
zinc ion at the centre of the maĐƌoĐǇĐle of these ĐoŵpouŶds alteƌs the π eleĐtƌoŶs 
that make up the chromophore producing a different spectrum. 
NMR analysis of Zby shows that apart from the central zinc ion the other chemical 
features of this compound remain the same relative to Hby with no change in the 
amount and position of the 1H atoms making up Zby. The chemical environment 
of some of these 1H atoms is different resulting in different chemical shifts as 
detected by NMR spectroscopy. The main changes when comparing the chemical 
shifts of 1H atoms of Hby and Zby occur at the C10 meso position as well as C19. 
These 1H atoms are attached directly to the macrocycle and as such, feel acutely 
any changes in chemical environment as a result of zinc being present at the 
centre of the macrocycle.   
While NMR data gives the position of each 1H atom relative to one another it is 
unable to give the absolute structure of the molecule. In order to determine the 
absolute structure of Zby the compound was crystallised and the structure solved 
by X-ray diffraction. The crystal structure of Zby is shown in Figure 5:3:1 














The crystal structure of Zby shows a highly distorted corrin ring. The C1 carbon 
atom is pushed below the plane of the corrin macrocycle in order to position the 
pyrrole nitrogen atom of ring A in such a way that the zinc ion is co-ordinated. 
This distortion of the corrin ring is also seen in cobalt containing corrins as both 
Zn2+ and Co2+ ions have similar ionic radii. Recent work concerning the crystal 
structure of rhodibalamin suggests that Rh3+ is a better fit for the corrin 
macrocycle than Co3+ due to the larger radius of the rhodium ion. Rh3+ has a 
similar ionic radius to Co2+ it is therefore hypothesised that the corrin ring of B12 
evolved to stabilise the transition between Co3+ – Co2+ – Co1+ ions. This cycling 
between cobalt species is important for the function of cobalamin as a cofactor 
(MetH). 
 
Figure 5:3:1: Crystal structure of Zby. The amide groups of sidechains 
b,d and e can adopt multiple conformations confusing their absolute 
positons in the crystal lattice. As the ionic radius of zinc is somewhat 
small than cobalt the corrin ring is distorted in order to provide the 4 
pyrrole nitrogen atoms as ligands to chelate zinc.  
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In the presence of light Zby degrades to form yellow coloured compounds. The 
UV-vis spectrum of the yellow product of Zby is shown in Figure 5:2:9. This 
property of zinc containing corrins has been documented previously 
(Koppenhagen and Pfiffner 1970). The mechanism by which these molecules 
degrade remains unclear. The equivalent metal-free compounds Hby and Hbl are 
more stable in the presence of light, retaining the same UV-vis spectrum over 
time, although it is also possible for these compounds to form a lactam between 
C6 and sidechain c (Grüning et al 1985). Previous work concerning the yellow 
products of cobalt containing corrins demonstrated that a C6 lactam can be 
formed in this set of molecules (Bonnett 1963). The formation of yellow 
compounds in zinc containing corrins appears to be more rapid than the 
formation of yellow corrins when the corrin contains either cobalt or is metal free. 
This observation could implicate the zinc ion in the possible degradation pathway 
of Zby.  
The yellow colour of the degraded product of Zby indicates a change in the 
conjugation of the macrocycle of Zby. It has been suggested that the acetamide 
sidechain c is the most predisposed to lactam formation at either C6 or C8. 
Formation of a bond between C8 and the nitrogen atom of sidechain c causes no 
disƌuptioŶ to the ĐoŶjugated π sǇsteŵ aŶd ƌesults iŶ Ŷo ĐhaŶge to the UV-vis 
spectrum. In contrast formation of a lactam between C6 and sidechain c would 
result in disruption of the double bond predicted to be at this position and by 
extension alter the UV-vis spectrum of this new molecule. A similar lactam is 
found as a feature of the nickel containing isobacteriochlorin co-enzyme F430 
(Figure 1:1:1), which is also bright yellow (Thauer 1998). 
 
The synthesis of Zbl from Zby and free lower nucleotide loop was achieved with a 
yield of around 96 % Zbl after purification. The reaction required near 
stoichiometric amounts of the reagents with a slight excess of lower nucleotide 
loop (1.1 molar equivalents) being used. A comparison of the lower loop coupling 
reactions with Hbl and Zbl shows that the presence of zinc at the centre of the 
corrin macrocycle significantly improves the efficiency of the coupling reaction. 
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HPLC analysis of the two reaction mixtures after 4 hours shows that attachment 
of the lower nucleotide loop is complete after this time whereas a majority of the 
Hby present remains unreacted (Figure 5:2:22). It is predicted that the coupling 
reaction between Zby and lower nucleotide loop proceeds faster than the 
analogous reaction with Hby due to the co-ordination of the lower nucleotide 
loop. The pre-positioning of the loop in such way relative to sidechain f that the 
carbodiimide coupling of the two compounds is enhanced. Adapting this synthetic 
scheme for the production of additional metal analogues it would be important 
to select a metal ion that is capable of harbouring at least 5 ligands in solution in 
order to take advantage of this prepositioning to improve the efficiency of this 
reaction.  
There is some variety in the structures of cobamides synthesised by bacteria and 
archaea. While the cobalt containing corrin system of these molecules remains 
the same the nature of the lower loop exhibits some variation between organisms 
(Stupperich et al 1990; Seth et al 2015). The synthesis of Zbl (Section 5:2:7) used 
a dimethyl benzimidazole containing lower nucleotide loop to produce the zinc 
analogue of B12. DMB is the preferred lower nucleotide loop for humans as well 
as a number of enteric bacteria. The synthetic scheme used to synthesise Zbl 
could be adapted to allow for the attachment of alternative nucleotide loops. The 
sǇŶthesis of ǀaƌious α-ribonucleotides have been described previously (Chandra 
et al 2005, 2006, 2008) these synthetic schemes could be adapted to produce a 
number of naturally occurring and unnatural nucleotide loops. By producing 
metal analogues of B12 that contain the preferred lower nucleotide loop for 
certain subsets of bacteria (Kräutler et al 1988, Kräutler et al 2003, Stupperich et 
al 1988). These analogues can be specifically targeted towards certain bacteria 
selectively delivering a compound capable of disrupting B12 dependent 
metabolism in these organisms.       
The central zinc ion of Zbl is expected to be pentacoordinate. Four of these ligands 
are provided by the pyrrole nitrogen atoms of the macrocycle (Huber et al 2008). 
The remaining fifth ligand in Zbl is expected to be provided by the DMB group of 
the lower nucleotide loop. NMR analysis of Zbl, in particular the ROESY 
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experiment shows, through space correlations between 1H atoms of groups 
attached to the ring of Zbl interacting with 1H atoms of the lower nucleotide loop. 
These through space correlations between the 1H atoms of the α-facing methyl 
groups (C1A and C7A) with C2N and C10N of DMB support a base on conformation 
for Zbl at neutral pH (Figure 5:2:17).  
Both Zby and Zbl inhibit the growth of B12 dependent S. enterica in solid culture. 
However, the growth phenotype when each zinc compound is mixed with B12 
differs between the two. When Zby is mixed with B12 and dropped onto a bioassay 
plate the area of growth of S. enterica remains the same but the density of the 
areas of growth is reduced (Figure 5:2:8). In contrast when Zbl is mixed with B12 
and dropped onto a bioassay plate the area of S. enterica growth increases but 
the density of the spots is reduced in comparison to a Cbl only control (Figure 
5:2:19).  
Zby and Zbl exhibit different growth phenotypes when these each of these 
compounds are mixed with a solution of B12 and applied to a S. enterica AR2680 
cysG, metE bioassay plate (Figure 5:2:8, Figure 5:2:20).  
When a mixture of B12 and Zbl was applied to a S. enterica bioassay plate the area 
of growth in Zbl treated areas was larger than that of the B12 only control area but 
with a reduced cell density. Previous work has shown that the rhodium analogue 
of B12, adenosyl-rhodibalamin has a similar effect on the growth of S. enterica 
under bioassay conditions (Widner et al 2016). The growth phenotype observed 
when S. enterica was exposed to adenosyl-rhodibalamin in conjunction with B12 
was areas of growth with a diameter significantly larger than that of the control 
spots but with a lower density of bacteria. Comparison of the data presented in 
this paper with experimental data shown in Figure 5:2:20 shows that adenosyl-
rhodibalamin has a similar effect on the growth of S. enterica as Zbl.    
It was hypothesised by Widner et al that adenosyl-rhodibalamin was able to 
influence the expression of the B12 uptake protein BtuB by binding to a riboswitch 
element present upstream of the gene coding region of the mRNA. Riboswitch 
elements are found in a number of bacteria and act as a mechanism by which the 
presence of certain metabolites or other molecules can modulate the expression 
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of various proteins (Mandal et al 2004). The presence of adenosyl-cobalamin 
switches off the expression of BtuB once a certain threshold level of B12 is 
acquired by the cell. Therefore, the larger areas of growth with reduced density 
is due to adenosyl-rhodibalamin being taken up by S. enterica and switching off 
translation of BtuB. In so doing the cells take up less B12 resulting lower growth 
but allowing B12 to diffuse further across the plate.  
It has been shown that adenosyl-cobalamin has the greatest inhibitory effect on 
expression of BtuB. While the ring portion is the main determinant for binding to 
the riboswitch element of BtuB both the lower nucleotide loop and upper 
adenosyl groups are important recognition elements (Gallo et al 2008). Zbl is 
lacking an upper adenosyl moiety but the presence of a lower nucleotide loop is 
probably what allows Zbl to interact with the riboswitch element of BtuB 
switching off expression as the growth phenotype of Zby and Hby are distinct from 
Zbl.  
When supplemented with Zby the size of the B12 induced growth area of S. 
enterica stays somewhat constant but with reduced density (Figure 5:2:8). It is 
possible that Zby is able to compete with B12 for some aspect of the uptake system 
or is able to bind to the B12 dependent methionine synthase that S. enterica 
requires for growth under the bioassay conditions. The reduced growth of S. 
enterica without an increase in diameter of the area of growth may suggest that 
Zby is inhibiting the growth of S. enterica through interaction with MetH. The size 
of the growth area reflects the amount of B12 available to S. enterica a set distance 
away from the point of application of the B12 solution.  
Therefore, in order to maintain the same area of growth the same amount of B12 
needs to be sequestered by cells within that area. Sequestering of B12 prevents its 
diffusion further out over the plate. Due to the lower density of cells within the 
growth area of the Zby treated areas the amount of B12 per cell must be higher in 







Zby was synthesised by inserting zinc into the macrocycle of Hby, the reaction 
scheme based upon the previous synthesis of Zbl from Hbl allowed for the 
efficient conversion of Hby to Zby.  
Zbl was synthesised from Zby and free lower nucleotide loop. Attachment of the 
lower nucleotide loop was enhanced by the presence of a central zinc ion 
presumably by pre-positioning of the lower nucleotide loop through co-
ordination before formation of an amide bond between sidechain f and the lower 
nucleotide loop.  
NMR and mass spec characterisation of these compounds confirmed that the 
structure of each is consistent with the predicted structures presented for each 
molecule (Figure 5:2:1, Figure 5:2:13). 
Both Zby and Zbl failed to stimulate the growth of S. enterica under bioassay 
conditions when added to the plates alone. When these compounds were added 
to the plates in addition to B12 different growth phenotypes were observed. The 
observation of differing growth phenotypes indicates different modes of 
inhibition for the two zinc compounds.  
It is predicted that Zbl acts as an inhibitor through interaction with the BtuB 
riboswitch preventing S. enterica from taking up sufficient B12 for optimal growth. 
Lower concentrations of B12 per cell allows the remaining B12 to diffuse further 
resulting in a larger area of growth with a lower density of bacteria.  
Application of Zby in addition to B12 as part of the bioassay outlined in Figure 
5:2:8, results in a growth phenotype whereby the area of growth is the same as 
that of a B12 only control with lower cell density. This indicates that Zby is having 





























The biosynthesis of the main corrin component of B12 follows one of two well 
defined routes, typified by early or late cobalt insertion. As is the case with most 
biosynthetic pathways the intermediates involved are conserved between 
organisms capable of B12 biosynthesis. The conservation of B12 biosynthesis does 
not extend to that of the lower nucleotide loop as variation exists regarding the 
nature of this group (Kräutler et al 1988, Stupperich et al 1988). Different 
organisms display different preferences for the analogues of B12 that they will 
make and use. Allochromatium vinosum appears to be one of a few organisms 
that show some variation in the production of the core corrin ring component of 
B12, specifically the production of a B12 analogue lacking a central cobalt atom 
(Toohey et al 1965).  
Annotation of the A. vinosum genome shows that this organism harbours the 
genes required to form both an almost complete aerobic and anaerobic B12 
biosynthetic pathway. Notably genes associated with cobalt insertion are missing, 
as are genes associated with adenosylation of the central cobalt ion of B12 
intermediates. This organism is however, reported to produce Hbl the cobalt free 
analogue of B12. The lack of crucial biosynthetic genes alongside any annotated 
B12 dependent enzymes therefore calls into question whether A. vinosum requires 
B12 and the possible function, if any of Hbl. A. vinosum is an anaerobic bacteria 
dependent upon photosynthesis in order to live (Kampf et al 1980). The presence 
of a B12 dependent enzyme involved in a crucial step of bacteriochlorophyll 
biosynthesis leads to the conclusion that A. vinosum either acquires B12 from the 
environment, calling into question the utility of an almost complete set of B12 
biosynthetic genes or it is capable of B12 biosynthesis. Previous reports regarding 
the production of Hbl describe culturing A. vinosum in a growth media devoid of 
cobalt in order to stimulate the production of Hbl, these publications do not 
describe the production of cobalt containing corrins when cobalt is present.     
Isolation of CobQ from A. vinosum and its subsequent incubation with glutamine, 
ATP and HBAd results in the generation of Hby, the cobalt free analogue of cobyric 
acid. The action of A. vinosum CobQ on HBAd represents an out of turn step when 
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compared to the aerobic biosynthesis of B12 in other organisms. The pathway in 
R. capsulatus and other organisms that follow the aerobic biosynthetic pathway 
for B12 amidation of sidechains b, d, e and g follows cobalt insertion and 
adenosylation. In the case of the R. capsulatus CobQ this enzyme will only act 
upon cobalt containing, adenosylated substrates.  
A. vinosum CobQ is undoubtedly a useful tool for the synthesis of metal analogues 
of B12. The substrate specificity of A. vinousm CobQ allows for the production of 
B12 analogues that cannot be stably adenosylated. Specific amidation of 
sidechains b, d, e and g while leaving sidechain f differentiated is technically one 
of the more challenging aspects of the synthesis of B12 analogues. While it would 
be possible to amidate these groups chemically the lack of specificity afforded by 
such an approach would result in a complex mixture of compounds with various 
patterns of amides requiring a complex chromatographic separation of the 
products. Instead, enzymatic conversion of HBAd to Hby results in the specific 
formation of the target compound. The chromatographic behaviour of the lesser 
amidated species produced as part of the in vitro conversion of HBAd to Hby 
indicates that amide groups are added in a specific order to HBAd. If the action of 
CobQ was random then it would be expected that a larger number of species 
could be detected by HPLC (Williams et al 2007). 
The chemical properties of Hby make it ideal as a starting point for the synthesis 
of metal analogues of B12. The production of Hby in vivo was explored as part of 
the effort to develop an efficient workflow for the production of mg amounts of 
Hby. To this end the plasmid pET3a-Hby was produced, containing all the genes 
necessary for the production of Hby. Expression of pET3a-Hby in E. coli BL21 
(DE3)-plysS cells resulted in the formation of Hby. However, the majority of the 
Hby produced in this way was found in the growth media as opposed to the cell 
pellet as is the case for HBAd. Interestingly Hby is the only corrin compound found 
in the growth media of cells expressing pET3a-Hby. The lack of lesser amidated 
species within the growth media would suggest that Hby is being specifically 
transported out of the cell as compounds with fewer amide groups can be isolated 
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form the cell pellets of these cultures. The mechanism by which Hby export occurs 
is currently unknown as no system for B12 export has been described so far for 
any organism. There is, however, some evidence that B12 export exists as some 
algae and bacterial communities form symbiotic relationships based upon the 
sharing of a number of compounds including cobalamins (Croft et al 2005, Taga 
and Walker 2010). 
As a proof of concept for the synthesis of a metal analogue of B12, zinc was 
inserted into the macrocycle of Hby to form Zby. Zinc chelation was achieved in a 
single step by heating Hby with an excess of zinc acetate in aqueous solution 
under an argon atmosphere. The resulting compound, Zby, had chemical 
properties distinct from the starting material, most notably in the nature of the 
UV-vis spectrum of Zby relative to Hby. The largest changes in the UV-vis spectrum 
centre on a bathochromic shift of ďoth the α aŶd ɶ ďaŶds of )ďǇ ƌelatiǀe to HďǇ. 
This is coupled with the disappearance of two small maxima normally present in 
the UV-vis spectrum of Hby at 396 and 378 nm. Changes to the UV-vis spectrum 
reflect changes within the corrin macrocycle as the zinc ion influences the 
deloĐalised π eleĐtƌoŶs of the ƌiŶg. AŶalǇsis of )ďǇ ďǇ ŵass speĐtƌosĐopǇ 
confirmed the presence of zinc within the macrocycle of this compound due to 
the unique distribution of isotopes. Zinc has a number of stable naturally 
occurring isotopes, the distribution of which is reflected in the isotopic 
distribution of Zby ions when analysed by mass spectroscopy.  
Zby was expected to harbour many of the same physical properties as Hby. 
However, unexpectedly, the presence of a zinc ion at the centre of Zby results in 
the formation of a compound that is highly sensitive to visible light. Under 
conditions of direct illumination solutions of Zby degrade through formation of a 
yellow compound after a few hours. The same degradation occurs with Hby but 
over an extended time scale taking days for the same transformation to occur.  
The synthetic steps required for the production of Zbl from HBAd can potentially 
be completed in any order regarding the timing of metal insertion relative to 
lower loop attachment. While the synthesis of Hbl from Hby shows that it is 
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possible to attach the lower nucleotide prior to insertion of a central metal ion, 
this step is far less effective than the analogous reaction with a metal containing 
corrin. The presence of a metal ion at the centre of the corrin macrocycle 
enhances the attachment of the lower nucleotide loop through co-ordination of 
the lower nucleotide loop prior to bond formation with sidechain f. Interestingly, 
nature makes no use of the pre-positioning of the nucleotide and instead relies 
upon attachment of the lower nucleotide loop in a piecemeal fashion with the 
components spatially arranged via binding to biosynthetic enzymes (Blanche et al 
1995).  
In order to support the theory that the presence of a metal ion at the centre of 
Zby would enhance the nucleotide loop attachment reaction, the co-ordination 
of the zinc ion of Zby by an analogue of DMB was investigated. Here N-
methylimidazole was added to a solution of Zby and changes to the absorption 
spectrum measured. Changes to the UV-vis spectrum of Zby under increasing 
concentrations of N-methylimidazole indicates that zinc is co-ordinated by N-
methylimidazole. Changes to the UV-vis spectrum of Zby in the presence of N-
methylimidazole can be detected due to the intimate relationship between the 
central zinc ion and delocalised electrons surrounding the corrin ring. Changes in 
the outer electrons of zinc through co-oƌdiŶatioŶ of a ligaŶd aƌe ͞ƌepoƌted͟ ďaĐk 
to the π electrons of the corrin ring therefore altering the UV-vis spectrum of the 
compound (Butler et al 2005).  
All of the intermediates produced en-rotue to Zbl were analysed by NMR 
spectroscopy. Initial spectra were collected when Hby was dissolved in D2O and 
were sufficient to assign the core structure of the compound. As the 1H atoms of 
the amide groups are solvent exchangeable experiments conducted in D2O could 
not provide any information about the position of the amide groups-  In order to 
define the positon of these groups further experiments were conducted in 90 % 
H2O, 10 % D2O. These spectra confirmed the presence of amide groups at 
sidechains a, b, c, d, e, and g, with no amide group present at sidechain f. 
Assignment of the positions of the amide groups and the position of 1H atoms 
attached to the macrocycle, peripheral methyl group and sidechains of Hby 
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allowed the proposed structure of this compound to be validated. Spectra for Zby 
and Zbl were collected in D2O only as the amide sidechains were expected to 
remain unchanged relative to Hby, apart from sidechain f of Zbl which is the site 
for lower loop attachment. The chemical shifts of some of the 1H atoms attached 
directly to the macrocycle of Zby and Zbl are shifted relative to Hby. Incorporation 
of zinc into the corrin ring of Hby results in a shift for the 1H atom attached to C3 
to a higher field positon (3.49 ppm Hby, 3.56 ppm Zby) this shift indicates that the 
1H atom at C3 of Zby is de-shielded relative to Hby. The remaining macrocycle 
attached 1H atoms are shifted to a low field positon in the 1H spectrum of Zby 
relative to Hby. These shifts indicate a greater degree of electron density in the 
vicinity of these atoms as a result of the centrally chelated zinc ion. Attachment 
of the lower nucleotide loop to Zby results in some additional changes to the 
chemical shifts of macrocycle attached 1H atoms. The biggest changes are the high 
field shift for signals associated with 1H atoms attached to C3 and C18 relative to 
Zby. Zbl C3 has a chemical shift of 3.61 ppm whereas the same 1H atom of Zby has 
a chemical shift of 3.56 ppm. Zbl C18 has a chemical shift of 3.8 ppm whereas Zby 
















 Figure 6:1:1: Overlay of Hby, Zby and Zbl 1D 1H NMR spectra. Generally the signals associated with the corrin attached 
methyl groups cluster together apart from the C1A methyl group of Zbl. The largest differences in the chemical shifts 
between compounds can be seen in 1H atoms attached directly to the corrin ring. 
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The greatest difference in chemical shifts between the 1H spectra of Zby and Zbl 
is seen at C18 where the signal for the 1H atom at this position is shifted to a low 
field positon. It has been suggested that the electron withdrawing properties of 
the lower nucleotide loop is responsible for this shift. The crystal structure of Zby 
(Figure 5:3:1) shows that C18 is bent down towards the α face of the molecule. 
This ruffling is expected to remain after attachment of the lower nucleotide loop 
bringing C18 and its attached 1H group close to the nucleotide portion of the lower 
loop. The proximity to DMB may therefore be sufficient to explain the shift of the 
1H signal at C18 (Bax et al 1987).  
Hby, Zby and Zbl were tested for biological activity against a B12 dependent strain 
of S. enterica. Due to the metabolic cost of producing cobalamins many organisms 
import intermediates of B12 biosynthesis even if they are capable for its de-novo 
biosynthesis (Woodson and Escalante-Semerena 2003). The earliest intermediate 
taken up in this way is cobyric acid. As Hby and Zby are the metal free and zinc 
containing analogues of cobyric acid they would also be expected to be taken up 
by S. enterica. Zbl is the zinc analogue of cobalamin and should therefore be taken 
up via the same pathway as B12. Supplementation of S. enterica with either Zbl, 
Zby or Hby alone results in no growth of S. enterica growth demonstrating that all 
of these compounds are unable to fulfil the role of methylcobalamin in S. enterica 
MetH or are not converted to a compound that can replace methylcobalamin.  
When these compounds are supplied to S. enterica in conjunction with B12 they 
perturb the stimulatory effect B12 exerts, reducing S. enterica growth. Addition of 
Zbl in conjunction with B12 results in the area of S. enterica growth increasing 
relative to a B12 only control but having a lower cell density. A similar phenotype 
has been observed when the same bioassay system was exposed to 
adenosylrhodibalamin in conjunction with B12 (Widner et al 2016). It was 
postulated that adenosylrhodibalamin is able to interact with the B12 dependent 
riboswitch that controls expression of BtuB, a key component of the B12 uptake 
machinery in a number of organisms. It is possible that Zbl is able to interact and 
with and ultimately supress the expression of BtuB in a similar fashion to 
adenosylrhodibalamin as indicated by similarities in the growth phenotype 
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exerted by these two compounds (Widner et al 2016). Previous work has shown 
that the BtuB riboswitch from E. coli has a preference for adenosylated 
compounds but is still able to bind non-adenosylated compounds provided the 
lower nucleotide loop is present (Gallo et al 2008). Neither Zby nor Hby are 
predicted to interact with the BtuB riboswitch due to the lack of a lower 
nucleotide loop and would be expected to exhibit a growth phenotype distinct 
from Zbl and adenosylrhodibalamin if this was the case.  
When S. enterica is supplemented with either Hby or Zby in addition to B12 the 
growth of the organism is diminished relative to a B12 only control. The growth 
phenotype exhibited by these compounds is distinct from Zbl and 
adenosylrhodibalamin as the diameter of the area of growth remains then same 
or is reduced at higher Hby or Zby concentrations. It is likely that the mode of 
inhibition for these compounds is through competition with B12 for MetH binding 
and not through interaction with the BtuB riboswitch.    
The ubiquitous nature of carbodiimide coupling chemistry as a result of its use in 
peptide synthesis means that functional groups can be attached to either free 
amino or carboxylic acids containing compounds such as analogues of cobyric 
acid. These groups could range from fluorescent compounds to analogues of the 
lower nucleotide loop. Modification of Hby or a metal analogue of Hby through 
attachment of groups to sidechain f could potentially be used as a method to bring 
compounds into bacterial cells. Previous work has detailed how B12 can be used 
as a ͞TƌojaŶ hoƌse͟ to sŵuggle cytotoxic or antibiotic compounds into cells. 
Previous approaches for the synthesis of this class of compound have focused on 
attachment of groups to the central cobalt ion, the ribose moiety of the lower 
nucleotide loop or by direct attachment to the peripheral sidechains (Gruber et al 
2011, Kunze et al 2004, Petrus et al 2009). Each of these approaches is potentially 
hampered by B12 uptake as the uptake of B12 is tightly controlled through 
translation level control of the expression of the BtuB, BtuC, BtuD import system. 
Once a certain threshold level of B12 is reached expression of these elements is 
switched off and further B12 uptake is no longer possible. This B12 sensor therefore 
limits how much B12 and by extension B12 analogue can be taken up by individual 
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cells. This may be problematic if the threshold for the activity of the attached 
group is higher than the intracellular concentration of B12 it is possible to achieve. 
Cobyric acid is unable to actuate the BtuB riboswitch of E. coli but is still taken up 
by this organism (Gallo et al 2008). Analogues of cobyric acid prepared form Hby 
could therefore be used to import compounds of interest into cells at a higher 
concentration compared to conjugation to B12.    
This work has outlined a synthetic scheme for the synthesis of zincobalamin. The 
modular nature of the steps should allow for the adaptation of this scheme to 
produce a number of metal analogues of B12. The most important considerations 
when adapting this synthesis concern the co-ordination chemistry of the metal 
ion to be inserted. It would be preferable to select a metal ion that is able to co-
ordinate at least 5 ligands in order to take advantage of the enhancement of lower 
loop attachment by pre-positioning nucleotide.  
It has been demonstrated in this work and within the literature that metal 
analogues of B12 are able to interfere with B12 dependent processes within 
bacterial cells. Due to the role methylcobalamin plays in the recycling of 
tetrahydrofolate and the synthesis of purine nucleotides rapidly dividing cells 
have a high requirement for B12. Metal analogues of B12 may therefore disrupt the 
B12 dependent metabolism of these cells. Through production of metal analogues 
of B12 it should be possible to produce a number of compounds and screen for 
enhanced anti-microbial or anti-cancer activity. Metal analogues of B12 may also 
be used to investigate the B12 metabolism of various organisms as they are able 
to induce a B12 deficient state through competitive uptake and binding to B12 
dependent enzymes in vivo. The evolutionary rational behind natures selection of 
cobalt for the centre of cobalamin may also be investigated through the synthesis 
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